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ABSTRACT 
 
ASHLEY KALLMAN: Influence of Estrogen on IL-6 Response to Prolonged Treadmill 
Running in Elite Female Runners 
(Under the direction of Anthony C. Hackney, PhD, DSc) 
 
This study assessed the influence of estrogen (E2) on IL-6 and IL-1β responses to 
prolonged aerobic exercise. Eumenorrheic women (n = 10) completed 90-minute treadmill 
running bouts at 67% VO2peak during low E2 (LE) and high E2 (HE) hormonal conditions. 
Resting, immediate, 24-hour, and 72-hour post blood samples were collected to determine 
changes in cytokines. Resting blood samples for E2 confirmed appropriate hormonal status 
for both conditions. Overall IL-6 concentration was significantly higher in LE (main effect; p 
= 0.011); however, relative exercise IL-6 percent change was not different between hormonal 
conditions. Interleukin-1β was unobtainable due to procedural challenges. In conclusion, the 
influence of hormonal condition on IL-6 and IL-1β in response to exercise is still unclear; 
therefore, it cannot be suggested that highly trained female runners should alter their training 
program with regards to hormonal status. Additional research is essential to add to the 
limited literature on this topic. 
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CHAPTER I 
Introduction 
Cytokines are the first response of the immune system to stress, infection, or damage 
to muscle (Corwin, 2000). Cytokine secretion is stimulated by growth, illness, injury, 
inflammation, or stress (Corwin, 2000). Cytokines exist in both pro- and anti-inflammatory 
forms. In general, pro-inflammatory cytokines act as messengers by binding to damaged 
tissue and signaling other immune cells to contain and eradicate the damaged tissue, 
promoting healing and recovery (Corwin, 2000; Pederson, Ostrowski, Rohde, & 
Bruunsgaard, 1998).  Anti-inflammatory cytokines are released in response to elevated pro-
inflammatory cytokine levels; their intent is to mitigate and inhibit the actions and further 
secretion of pro-inflammatory cytokines (Corwin, 2000; Pederson et al., 1998).  
One of the prominent pro-inflammatory cytokines is interleukin-1β (IL-1β) (Corwin, 
2000). Interleukin-1β stimulates the secretion of interleukin-6 (IL-6) via activation of 
macrophages and monocytes in response to tissue damage (Corwin, 2000).  Interleukin-6 has 
pro- as well as some anti-inflammatory characteristics. Interleukin-6 stimulates acute phase 
protein secretion from the liver, which helps to increase recognition and destruction of 
foreign molecules (Abbas & Lichtman, 2003). Receptors for IL-6 are housed on both the 
anterior pituitary and the adrenal gland (Fischer, 2006). Interleukin-6 will stimulate the 
release of cortisol via activation of the hypothalamic-pituitary-adrenal regulatory axis and 
direct stimulation of the adrenal cortex (Fischer, 2006; Nieman et al., 1998). Increases in the 
concentration of cortisol will feedback to inhibit further secretion of IL-6 and IL-1β (Nieman 
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et al., 1998). Additionally, elevated IL-6 concentrations increase expression of the anti-
inflammatory cytokine interleukin-1 receptor alpha (IL-1ra), which inhibits the release of IL-
1β, subsequently reducing IL-6 release (Corwin, 2000; Pederson et al., 1998). This system of 
checks and balances between pro-inflammatory and anti-inflammatory cytokines is 
purportedly in place to avoid over-activation of the immune system. Such checks and 
balances are critical because a non-regulated immune system can lead to detrimental 
physiological effects; the most serve being an autoimmune disease (Corwin, 2000).  
An acute bout of exercise is known to increase levels of IL-6 and IL-1β immediately 
post-exercise and for hours into recovery from exercise.  The magnitude of the IL-6 and IL-
1β response to exercise is dependent on exercise mode, intensity, and duration (Pederson et 
al., 1998). Aerobic exercise bouts greater than 60 minutes above 60% maximal aerobic 
capacity (VO2max) elicit a significant increase in IL-6 (Brenner et al., 1999; Ostrowski, 
Rohde, Asp, Schjerling, & Pederson, 1999; Nieman et al., 1998; Nieman et al., 2001) and IL-
1β concentrations in the blood (Ostrowski et al., 1999; Nieman et al., 2001). Furthermore, the 
IL-6 and IL-1β responses are significantly more elevated from eccentric exercise compared 
to concentric exercise (Bruunsgaard et al., 1997; Nieman et al., 1998). Regrettably, however, 
the research literature examining the cytokine response to exercise is primarily limited 
primarily to male populations and few studies have examined female subjects despite the 
large number of women participating in exercise and sport. Nieman et al. (1998; 2001) did, 
however, incorporate female subjects; nonetheless, reported no apparent significant 
differences between the genders with respect to cytokine responses. Conversely, Edwards, 
Burns, Ring, and Carroll (2006) reported a significant difference between genders in cytokine 
responses; however, these investigators did not control for the menstrual phase cycle 
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fluctuations in estrogens (E2) of the female subjects. This last point, control of the menstrual 
cycle, is of key importance as many hormonal responses are related to immune responses, 
such as E2, and are known to fluctuate across the cycle (Angstwurm, Gartner, & Ziegler-
Heitbrock, 1997; Bouman, Moes, Heineman, de Leij, & Faas, 2001; Lynch, Dinarello, & 
Cannon, 1994; Willis, Morris, Danis, & Gallery, 2003); one such hormone being E2. High E2 
(HE) concentrations are observed at ovulation as well as during the luteal phase, while low 
E2 (LE) concentrations are present during menses and the follicular phase of the menstrual 
cycle (Williams & Larsen, 2003). 
Studies evaluating the relationship between basal resting E2 and IL-6 are conflicting. 
Some have suggested non-significant fluctuations in IL-6 between varying concentrations of 
E2 (Al-Haarthi et al., 2000). Others support elevated IL-6 concentrations or elevated immune 
constituents known to stimulate secretion of IL-6 during HE compared to LE hormonal 
conditions (Bouman et al., 2001; Willis et al., 2003). Conversely, Angstwurm et al. (1997) 
found an inverse relationship between concentrations of E2 and IL-6; an elevated 
concentration of E2 was associated with reduced IL-6 while a lower concentration of E2 was 
associated with increased IL-6. Literature evaluating resting IL-1β and E2 is also divergent. 
Some research shows higher IL-1β concentration during periods of LE (Lynch et al., 1994) 
while others suggest a significantly greater IL-1β concentration during the HE phase of the 
menstrual cycle (Willis et al., 2003). These demonstrated fluctuations in basal, resting IL-6 
and IL-1β to varying levels of E2 beg the question - Is there an altered cytokine response 
following exercise at different levels of E2? Researchers have not apparently directly 
assessed this question in a clear and systemic fashion. 
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Researchers have, however, indirectly looked at aspects of the above question by 
examining exercise induced muscular damage in females (i.e., muscle damage can  provoke 
cytokine responses). Tiidus et al. (2001) observed a decreased neutrophil concentration in 
response to reduced creatine kinase levels [CK] (i.e. biological marker of muscle damage) 
following one hour of inclined running in ovarectomized rats given estrogen supplementation 
compared to non-supplemented ovarectomized rats. Neutrophils attract monocytes, a major 
producer and secretory cell for IL-1β and IL-6, to the area of damage (Corwin, 2000; 
Pederson et al., 1998). Research has shown that E2 acts as an antioxidant, thereby reducing 
reactive oxygen species produced by neutrophil activity and can stabilize muscle membrane 
further reducing the potential for damage (Kendall & Eston, 2002).  If E2 supplementation 
reduced the neutrophil response, one would expect to see a reduction in cytokine response as 
well.   
Another study using human subjects observed a significantly greater increase in CK 
in women after eccentric exercise in LE compared to HE was observed (Carter, Dobridge, & 
Hackney, 2001). The authors speculated the lower CK observed in HE suggest E2 acts as a 
shield against muscle degradation and abated the inflammatory response which others have 
also proposed (Tiidus et al., 2001). Research has shown a postive correlation between CK 
levels and select cytokines and that muscle damage does cause local secretion of pro-
inflammatory cytokines (Pederson et al., 1998). Therefore, if higher E2 concentrations reduce 
muscle damage and the response of other immune cells known to stimulate cytokine release 
following exercise, one would expect to see a reduced pro-inflammatory cytokine response 
during periods when E2 is elevated. 
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Purpose of the Study: 
 The primary purpose of this study was to evaluate the IL-6 and IL-1β responses when 
resting E2 concentrations were elevated and reduced, (as manipulated by menstrual cycle 
phase), following prolonged moderate intensity treadmill running in females. On separate 
days, subjects performed an exercise test on the treadmill to determine their VO2max, two 
90-minute treadmill running bouts at 70% of their VO2max, and had blood drawn before, 
immediately post, 24-hours post, and 72-hours post the 90-minute running bouts. The 90-
minute running bouts and subsequent blood draws were performed at the two specified 
hormonal conditions: low E2 (LE) and high E2 (HE) concentrations.  
Research Questions: 
1. Is there a significant interaction effect between IL-6 concentration and hormonal 
condition? 
a. Is there a significant difference in IL-6 concentration at rest between HE and 
LE conditions?  
b. Is there a significant difference in IL-6 concentration immediately post 
exercise between HE and LE conditions? 
c. Is there a significant difference in IL-6 concentration 24 hours post-exercise 
between HE and LE conditions? 
d. Is there a significant difference in IL-6 concentration 72 hours post-exercise 
between HE and LE conditions? 
2. Is there a significant interaction effect between IL-1β and hormonal condition? 
a. Is there a significant difference in IL-1β concentration at rest between HE and 
LE conditions? 
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b. Is there a significant difference in IL-1β concentration immediately post 
exercise between HE and LE conditions? 
c. Is there a significant difference in IL-1β concentration 24 hours post-exercise 
between HE and LE conditions? 
d. Is there a significance difference in IL-1β concentration 72 hours post exercise 
between HE and LE conditions?  
Research Hypotheses: 
1. A significant interaction effect will exist between IL-6 and hormonal condition. 
a. Interleukin-6 concentration will be significantly greater at rest in women 
during LE condition compared to HE.  
b. The magnitude of change from rest in IL-6 will be significantly greater 
immediately post exercise in women during LE condition compared to HE.  
c. The magnitude of change from rest in IL-6 will be significantly greater 24 
hours post-exercise in women during LE condition compared to HE. 
d. The magnitude of change from rest in IL-6 will be significantly greater 72 
hours post exercise in women during LE condition compared to HE.  
2. A significant interaction effect will exist between IL-1β and hormonal condition.  
a. Interleukin-1β concentration will be significantly greater at rest in women 
during LE condition compared to HE. 
b. The magnitude of change from rest in IL-1β will be significantly greater 
immediately post exercise in women during LE condition compared to HE 
c. The magnitude of change from rest in IL-1β will be significantly greater 24 
hours post-exercise in women during LE condition compared to HE.  
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d. The magnitude of change from rest in IL-1β will be significantly greater 72 
hours post-exercise in women during LE condition compared to HE.  
Definition of Terms: 
Estrogen (E2): Estrogen is the primary sex hormone for females. Estrogen is produced and 
secreted from the ovaries and exist in several forms (estrodial β-17 being the major). 
The level of circulating E2 is known to fluctuate throughout the menstrual cycle. In 
addition to its role in female reproductive development, E2 is believed to influence 
non-reproductive tissues (Ruggiero & Likis, 2002).   
Cytokine: Cytokines are small regulatory proteins in the innate immune system of the human 
body. Cytokines release is stimulated by stress, infection, illness, and inflammation 
(Corwin, 2000). Cytokines act to signal additional immune responses to contain and 
remove foreign or damaged substances (Corwin, 2000; Pederson et al., 1998). 
Cytokines can be either pro-inflammatory or anti-inflammatory. Predominant pro-
inflammatory cytokines include IL-1β and IL-6. Interleukin-6 also acts as an anti-
inflammatory cytokine in conjunction with IL-1ra to regulate the innate immune 
response. 
Prolonged running bout: Exercise that is performed on a treadmill at 70% of the subject’s 
VO2max at 0% grade for 90-minutes.  
Maximal Oxygen Consumption (VO2max): Maximal oxygen uptake is the maximal amount 
of oxygen that can be delivered and utilized by active muscles; it is a variable 
primarily used to assess the efficiency of the cardiorespiratory system (Plowman & 
Smith, 2003).   
 
  8 
Assumptions 
1. Subjects are healthy and free of infections. Injury or illness are known to elicit an 
immune response independent of E2.   
2. Subjects are not knowingly pregnant or trying to become pregnant. Pregnancy is 
accompanied by altered hormonal response and absence of menstruation, potentially 
altering cytokine response.  
3. The physical and emotional stress level of the subject is minimal. Stress is known to 
elicit an inflammatory response. 
4. Subjects refrain from no more than 30-minutes light exercise during the 72-hour 
window from the end of the 90-minute running bout and the 72-hour post blood draw. 
Additional exercise outside of daily living activities can elicit an additional 
inflammatory response.  
Delimitations 
1. Healthy, non-smoking, highly trained women runners between the ages of 18-30. 
2. The treadmill running bout is set at 70% VO2max for 90 minutes.  
3. Subjects had to complete a half marathon or equivalent distance within the last year, 
under 2 hours 30 minutes, with no associated injuries (Nieman et al., 2001).  
4. A minimum VO2max of approximately 45 ml/kg/min is required.  
5. Individuals must be currently training with a minimum training volume of 3 - 5 days 
a week, 45 - 120 minutes per session of aerobic activity.  
Limitations 
1. The inclusion criteria and study protocol led to a small sample size.  
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2. Only eumenorrheic women and oral contraceptive users were studied; therefore, the 
results are not applicable to men and may not be applicable to premenopausal, 
postmenopausal, or amenorrheic women. 
3. Only runners were tested; therefore, results may only be applicable to exercisers who 
run.  
Significance of Study 
 The results of this study will add to the limited body of knowledge available on the 
influence of E2 on cytokine expression in response to exercise within women. Additionally, 
IL-6 and IL-1β exert effects not only on damaged tissue and foreign microbes but have 
receptors on other tissues too including vascular, cardiac, bone, and nerve. The impact of IL-
6 and IL-1β on these tissues is reduced vasoreactivity, reduced heart contractility, and 
increased muscle and bone degradation (Moldoveanu, Shephard, & Shek, 2001). Elevated 
concentrations of IL-6 and IL-1β will only exacerbate the aforementioned effects leading to 
potentially a maladaptation within select physiological processes - these detrimental changes 
could potentially alter proper functioning and compromise physical performance. Most 
endurance training programs involve a tremendous volume of work, requiring consecutive 
days of prolonged and intense exercise.  The results of this study could also provide insight 
for women on the necessity of perhaps altering their training programs for optimal adaptation 
and minimal risk during different E2 concentrations based on IL-6 and IL-1β response 
potentially being greater in one hormonal condition compared to the other. 
  
 
CHAPTER II 
Review of Literature 
 This review of literature is organized in the following manner:  with a basic overview 
of general cytokine physiology and immunology. Next is a discussion on the cytokine 
response, namely IL-6 and IL-1β, to exercise in primarily male populations followed by the 
influence of gender on such responses. Exercise studies with only male cohorts will be 
organized based on exercise duration starting with the shortest duration (30 minutes) and 
ending with the longest (3.5 hours). Gender studies will be organized on whether or not they 
separated men and women, starting with not separating followed by separating. The gender 
studies using women, however, did not account for E2 fluctuations across the menstrual 
cycle. Therefore, E2 physiology and the influence of E2 on inflammatory markers, such as IL-
6 and IL-1β, at rest are also examined in this review. This section will be arranged based on 
studies with similar outcomes being grouped together. Next, this review will discuss the 
influence of E2 on muscle damage following exercise as muscle damage is strongly 
correlated to cytokine response. Studies utilizing animal models will be reviewed first, 
followed by studies utilizing human models. The review chapter will end with a look at 
studies directly measuring the influence of E2 on IL-6 and IL-1β in response to exercise. The 
review will conclude with a brief summary.  
Cytokine Physiology 
Cytokines are 6 - 70 kilodalton-sized glycoproteins secreted from both immune and 
non-immune cells in response to stress, growth, infection, trauma, and exercise (Corwin, 
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2000; Moldoveanu et al., 2001). In general, cytokines act as messengers, signaling further 
immune activation or inhibition (Corwin, 2000; Pederson et al., 1998). Cytokines exert their 
effect by binding to surface receptors on target tissues triggering a cascade of enzymes in the 
cell cytoplasm to bring about the desired response (Corwin, 2000).  Two groups of cytokines 
exist: pro- and anti-inflammatory.  
Immediately following infection, trauma, or certain forms of exercise, pro-
inflammatory cytokines such as IL-1 and IL-6 are released (Corwin, 2000; Moldoveanu et 
al., 2001). These cytokines initiate the inflammatory process. Inflammation is a protective 
mechanism utilized to contain and destroy foreign pathogens, remove damaged tissue, and 
stimulate repair and regeneration (Plowman & Smith, 2003). This is accomplished by 
signaling additional immune cells to the area of damage. The inflammatory response is 
typically robust. To regulate the inflammatory response, anti-inflammatory cytokines such as 
IL-1ra and IL-10 are released shortly after the aforementioned pro-inflammatory cytokines. 
The anti-inflammatory cytokines act to suppress the inflammatory response by inhibiting 
further secretion of pro-inflammatory mediators and reducing the activity of pro-
inflammatory mediators by blocking receptors with increased antagonist expression (Corwin, 
2000; Moldoveanu et al., 2001). As stated previously, regulation of the immune system 
between pro- and anti- inflammatory cytokines is necessary. A non-regulated immune system 
can lead to a compromised or excessive immune response resulting in increased infection or 
an autoimmune disease.  
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Table 1: Common immune cells - characteristics and function 
Cell Type What it is Function 
T-lymphocyte 
(T-cell) 
White blood cells matured 
in the thymus. 
 
Part of cell mediated 
immunity - primarily exerts 
its actions through immune 
cells. 
• Activated when foreign antigens bind to 
recognition site on the cell     
• Cytotoxic T-cells: directly destroy foreign 
pathogens via break down of cell 
membrane and nuclear material 
• Helper T-cells: enhance immune response 
through production and secretion of 
cytokines 
B-Lymphocyte 
(B-cell) 
White blood cells matured 
in bone marrow.  
 
Part of humoral immunity 
– primarily exerts its 
actions in bodily fluids, 
e.g. blood and lymph. 
• Activated when foreign antigens bind to 
recognition site on cell 
• Produce antibodies – protein that identifies 
antigens and marks it for destruction  
• Block antigen binding site inhibiting its 
attachment to host cells 
• Coat antigen attracting additional immune 
mediators (monocytes) to the area for 
containment and eradication of foreign 
material. 
Monocyte Phagocytic white blood 
cell that circulates in 
lymph and blood.    
• Ingests foreign material and destroys it via 
destruction of cell membrane and nuclear 
material 
• Presents fragments of the antigen to T-cells 
for immune cell proliferation 
• Produces and secretes cytokines 
Macrophage A monocyte that moved 
from blood or lymph to 
tissues and has become 
fixed within tissues. 
• Ingests foreign material and destroys it via 
destruction of cell membrane and nuclear 
material 
• Presents fragments of the antigen to T-cells 
for immune cell proliferation 
• Produces and secretes cytokines 
Neutrophil The most prominent 
phagocytic white blood cell 
that circulates in the blood.  
 
One of the first responding 
immune cells to foreign 
material. 
 
• Attracted to area of tissue damage or 
infection by chemoattractants. 
• Ingests the foreign material and destroys it 
via enzymes housed in granules within the 
cytoplasm, neutrophils generally die 
during the process 
• Produces reactive oxygen species during 
the breakdown of foreign material 
• Attracts monocytes to the area of damage  
Abbas & Litchman, 2003; Bouman, Heineman, & Fass, 2005; Kendall & Eston, 2002; 
Plowman & Smith, 2003  
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Interleukin-1β has been characterized as a potent pro-inflammatory cytokine, exerting 
its effects on other immune cells, vasculature, heart tissue, kidneys, pancreas, muscle, and 
bone (Corwin, 2000; Moldoveanu et al., 2001). Interleukin-1β perpetuates the pro-
inflammatory response by activating T and B cells, increasing cell adhesion molecule 
expression, stimulating the acute phase response of the immune system, and increasing 
further production of itself and other pro-inflammatory cytokines such as IL-2 and IL-6 
(Corwin, 2000; Moldoveanu et al., 2001). Furthermore, IL-1β increases the production of 
both prostaglandins and nitric oxide both of which are strong vasodilators (Corwin, 2000; 
Moldoveanu et al., 2001). Vasodialators repress the ability of smooth muscle to contract 
thereby reducing vasoreactivity of the vasculature. At the heart, IL-1β reduces the sensitivity 
of beta-receptors affecting the heart’s ability to forcefully contract (i.e. contractility) 
decreasing the amount of blood pumped out to the body (Moldoveanu et al., 2001). The 
combination of vasodialation and reduced contractility leads to a hypotensive state 
(Moldoveanu et al., 2001), potentially affecting the body’s ability to deliver oxygenated 
blood to organs. Interleukin-1β also causes the breakdown of bone by activating osteoclasts 
and muscle via stimulation of protein catabolism and degradation (Moldoveanu et al., 2001).  
Interleukin-6 is another prominent cytokine produced and secreted by almost all 
leukocytes as well as smooth muscle cells and adipocytes (Corwin, 2000; Moldoveanu et al., 
2001). Receptors for IL-6 are housed on other immune cells, liver, bone, and bone marrow 
(Moldoveanu et al., 2001). Interleukin-6 stimulates T-cell activation, anti-body formation, 
and the release of acute phase proteins from the liver (Corwin, 2000; Moldoveanu et al., 
2001). Acute phase proteins further amplify the inflammatory response by increasing 
neutrophil and monocyte mobilization to the area of damage and initiating repair of damaged 
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tissue (Plowman & Smith, 2003). Interleukin-6 also increases osteoclast activation 
perpetuating accelerated bone breakdown (Moldoveanu et al., 2001). At bone marrow, IL-6 
stimulates platelet formation increasing the potential for clot formation and this in turn 
increases the risk of blockages within the vasculature (Moldoveanu et al., 2001). Along with 
pro-inflammatory characteristics, paradoxically IL-6 exhibits some anti-inflammatory actions 
too [e.g. activation of the HPA-axis thereby increasing cortisol secretion – cortisol inhibits 
IL-6 release and increase expression of the anti-inflammatory cytokine IL-1ra] (Corwin, 
2000; Fischer, 2006; Nieman et al., 1998; Pederson et al., 1998).  
The mechanisms behind why a cytokine response occurs following exercise are not 
fully known or understood. Some suggest cytokines are released in response to muscle 
damage (Bruunsgaard et al., 1998). Muscle damage creates cell debris – a type of trauma, 
thereby stimulating a rush of cytokines to the area to remove and repair – i.e., inflammatory 
response (Moldoveanu et al., 2001). Others postulate endotoxemia – leakages of endotoxins 
from the gut as a result of blood flow redistribution away from the splanchnic region are a 
means that mediates the cytokine response (Pederson & Hoffman-Goetz, 2000). Another 
possibility is the increased reactive oxygen species as a result of neutrophil bursts 
encountered during exercise (Kendall & Eston, 2002). Finally, it is highly possible that all of 
these means and mechanism work in some degree of a synergistic fashion to provoke a post-
exercise cytokine response.  
IL-6 and IL-1β Response to Exercise 
The influence of various exercise protocols on IL-6 and IL-1β responses has been 
extensively studied and an exhaustive review of these works is beyond the scope of this 
chapter. Thus, only key studies will be discussed below.  
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Bruunsgaard et al. (1997) compared the influence of concentric versus eccentric 
cycling on blood IL-6 concentration. Nine trained (VO2max ~ 51 ml/kg/min) male subjects 
completed 2 separate exercise sessions: 30 minutes of normal cycling (concentric) and 30 
minutes of reverse braked cycling (eccentric) at approximately 60% VO2max. Blood samples 
were obtained pre, 20 minutes, 30 minutes, 2 hours, 2, 4, and 7 days post exercise. Results 
showed a significant elevation in IL-6 concentration during and following eccentric exercise 
compared to a non-significant increase during and following concentric exercise. The IL-6 
concentration was 0.78 pg/ml prior to starting the eccentric bout. Interleukin-6 peaked 2 
hours post exercise with a 5.74 fold increase above pre-exercise values (~ 4.5 pg/ml). While 
not statistically significant, IL-6 remained elevated above resting values 7 days post the 
eccentric exercise. The results of the study suggest that the mode of exercise muscular 
contraction performed influences the pro-inflammatory immune response.  
 Brenner at al. (1999) compared the IL-6 response following three different forms of 
exercise. Eight male subjects of average aerobic fitness (VO2max ~ 43 ml/kg/min) completed 
all exercise sessions. The three exercise sessions were: five minutes of cycling at 95% 
VO2max, a resistance circuit routine completing 3 rounds of 5 different exercises 
incorporating major muscles at an intensity level indicative of 50% VO2max, and a two-hour 
cycling bout at 63% VO2max.  A control, rest session of sitting for 5 hours was also 
conducted. Blood samples were taken pre, immediately post, 3 hours, 24 hours, and 72 hours 
post the sessions. The results showed only a significant elevation in IL-6 concentration 
following the two-hour cycling bout. Pre-exercise IL-6 concentration was 1.14 ± 0.32 pg/ml. 
Interleukin-6 peaked 3 hours post exercise at 6.06 ± 1.95 pg/ml, a 5.32 - fold increase. By 24 
- hours post exercise, IL-6 had returned to pre-exercise concentrations.  
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Suzuki et al. (2003) investigated the impact of a marathon race (26.2 miles) on 
cytokine secretion and its role in development of post exercise health status. Ten male 
subjects, training an average of 43 - 86 miles of running a week, competing in the 1999 
Beppu marathon were recruited from the study. Blood and urine samples were obtained 24 
hours prior to the start of the race and within 10 minutes of completion of the race. The 
average finishing time was 2:37 (hrs:min). A non-significant increase in blood IL-1β was 
observed following the marathon. The lack of elevation in IL-1β may be the result of 
accelerated clearance rate, blood sample timing, or their assay sensitivity. Furthermore, a 
significant increase in blood IL-6 was observed following the race (baseline: 1.27 ± 1.19 
pg/ml vs. post race: 101.4 ± 50.34 pg/ml). These results are in agreement with those of 
Brenner et al. (1999) who conducted a similar study observing changes following cycling 
instead of running.  
Nieman et al. (1998) compared the influence of carbohydrate (CHO) supplementation 
on cytokine response following 2.5 hours of cycling versus running at 75% VO2max. Ten 
highly trained subjects (VO2max ~ 55.6 ml/kg/min) subjects, two of which were women, 
completed four exercise conditions each: running with CHO solution, running with placebo 
(P) solution, cycling with CHO solution, and cycling with P solution. Blood samples were 
obtained pre exercise, immediately post, 1.5, 3, and 6 hours post exercise. Pre-exercise 
concentration was approximately 1 pg/ml for all conditions. All conditions saw a significant 
increase in IL-6 immediately following exercise; however, the greatest increase in IL-6 was 
the P running group (~ 51.6 pg/ml), while the least responsive condition was the CHO 
cycling group (~ 10.7 pg/ml). By the 6th hour of recovery all conditions were at or slightly 
above baseline values. The results show that both mode of exercise and supplementation 
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significantly influence IL-6 production. Running had a greater IL-6 response compared to 
cycling. The authors suggest running has a greater eccentric component compared to cycling, 
which has been shown to elicit a greater pro-inflammatory reaction. The P group had a 
greater IL-6 response compared to the CHO group. Carbohydrate supplementation minimizes 
plasma glucose fluctuations, reducing secretion of stress hormones, thereby reducing stress 
on the body – a mediator of pro-inflammatory activation (Nieman et al., 1998). 
Ostrowski et al. (1999) studied the effect of a marathon race on IL-1β and IL-6 levels 
in the blood. Ten highly trained (VO2max ~ 61.2 ml/kg/min) male subjects competing in the 
1997 Copenhagan marathon were recruited for this study. Blood samples were collected one 
week prior to the race, within 10 minutes of race completion, and every 30 minutes for the 
first 4 hours post race. The median finish time for the marathon was 3:27 (hrs:min). 
Interleukin-1β was significantly elevated immediately post (~ 1.75 pg/ml) and for the first 30 
minutes of recovery (~ 1.50 pg/ml).  Within two hours of recovery IL-1β had returned to pre-
race concentration (~ 1.0 pg/ml). Interleukin-6 significantly increased following the 
marathon, peaking at 75 pg/ml immediately post-race, and was still significantly elevated at 4 
hours post-race (~ 10 pg/ml). The results of this study are in line with those previously 
reported studies above.  
The studies reviewed in this section offer support for an elevated cytokine response 
following exercise. A limitation to the studies just noted is they employed primarily male 
populations; this is despite many women participating in regular strenuous exercise.  
Influence of Gender on Exercise Immune Response 
The numbers of studies investigating the influence of gender on cytokine responses to 
exercise are minimal. In 2001, Nieman et al. conducted a study exploring the influence of 
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age, gender, and CHO supplementation on immune response following a marathon. Ninety-
eight subjects, 12 were women, competing in the 1999 Charlotte or 2000 Boone marathon 
were divided into two groups: CHO or P. Subjects ingested 650 ml of their assigned solution 
30 minutes before the start of the race and 500 ml every half hour throughout the race. Blood 
samples were collected prior to the start of the race, within 5 minutes after completion of the 
race, and 1.5 hours post-race. The average intensity during the race was 78% of the subject’s 
maximal heart rate. The average finishing time was 4:28 (hrs:min). The authors indicated no 
significant differences were observed for age and gender grouping with respect to IL-1β and 
IL-6 following the race. For both the P and CHO groups plasma IL-1β was significantly 
elevated immediately following the event, but back to baseline values by 1.5 hours post race. 
Despite statistical significance, the magnitude of change from baseline to immediately post 
was minimal (0.04 - 0.15 pg/ml). Interleukin-6 was significantly elevated immediately and 
1.5 hours post exercise for both groups. While the CHO group saw a greater absolute 
increase in IL-6 concentration compared to the P group (CHO: 59.4 ± 8.0 pg/ml vs. P: 50.5 ± 
5.0 pg/ml), the magnitude of change was greatest for the P group (P: 42 - fold increase vs. 
CHO: 40 - fold increase from baseline values respectively). These results are in line with the 
earlier study Nieman et al. (1998) that demonstrated CHO supplementation attenuates the 
cytokine response to exercise. Additionally, the minimal increase in IL-1β and increase IL-6 
following prolonged exercise observed in this study is in agreement with the previous studies 
discussed (Brenner et al., 1999; Bruunsgaard et al., 1997; Nieman et al., 1998, Ostrowski et 
al., 1999; Suzuki et al., 2003).    
Edwards et al. (2006) compared the IL-6 response in men and women following two 
different types of exercise and a control, rest session. Twenty-four non-competitive active 
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subjects were recruited, 12 males and 12 females. Of the women, nine were on some form of 
birth control. The two exercise sessions were: a maximal cycle ergometer test followed by a 
steady state ride at 55% max power (Wmax) for a total of 45 minutes of work and 20 minutes 
of cycling at a defined workload (~ 77% Wmax for women, ~ 81% Wmax for men) followed 
by 25 minutes at 55% Wmax.  The control session was sitting on the cycle ergometer for 45 
minutes with no exercise. Blood samples were drawn pre-exercise, immediately post, 30, and 
60 minute post. The pre-exercise IL-6 concentrations were <0.5 pg/ml for all conditions. As a 
collective group, IL-6 increased significantly following both the maximal and submaximal 
sessions and displayed an upward trend at the last blood sample 1-hour post (maximal: ~ 1.95 
pg/ml; submaximal: ~ 1.75 pg/ml). When comparing men and women following the maximal 
session, the trend of IL-6 remained the same between genders immediately post and at 30 
minutes of recovery. However after 30 minutes of recovery, IL-6 decreased in men while 
continuing to increase significantly in women (men: ~ 1.1 pg/ml vs. women: ~ 2.95 pg/ml). 
The results of this study suggest gender does influence the pro-inflammatory cytokine 
response following high intensity exercise. The authors postulated that the divergent cytokine 
response was related to the different hormonal profiles of men and women.  
The articles reviewed in this section present divergent findings on gender and 
cytokine response following exercise. Within these studies hormonal status of the women 
subjects was not controlled.  
Estrogen Physiology 
Estrogen physiology has been thoroughly studied and a comprehensive review is 
outside the scope of this chapter. Therefore, the following section will give a brief overview 
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of estrogen metabolism, mechanism of action, and influences on non-reproductive related 
tissues.   
Estrogen, the primary sex hormone for women, is an 18-carbon steroid hormone 
produced via de novo lipogenesis of low-density lipoproteins primarily in the ovary, with 
small amounts produced in the adrenal cortex and adipose tissue (Enns & Tiidus, 2010; 
Williams & Larsen, 2003). Three main forms of estrogen exist: estrone (E1), estradiol-β17 
(E2), and estriol (E3) (Ruggiero & Likis, 2002). The dominance of one form of estrogen over 
another is dependent on reproductive stage (Ruggiero & Likis, 2002). Estrone is prominent 
following menopause, estriol is dominant during pregnancy, and estradiol is the dominant 
estrogen for non-pregnant females throughout the reproductive years (Ruggiero & Likis, 
2002). The primary focus of this thesis is the effects of estradiol on the immune response; 
therefore, the use of the word E2 throughout this document will refer to estradiol specifically 
despite estrogen encompassing all forms.  
Estrogen metabolism is regulated by a complex system of feed forward and feedback 
loops within the hypothalamic-pituitary-gonadal axis (Williams & Larsen, 2003). Estrogen 
levels fluctuate throughout the menstrual cycle (Bouman et al., 2005; Williams & Larsen, 
2003). This fluctuation is primarily dependent on the stage of follicular development from 
growth, differentiation, ovulation, and its eventual release if not fertilized (Constantini & 
Dubnov, 2005; Williams & Larsen, 2003). At the start of the cycle, denoted as the onset of 
menses, estrogen is low.  Low E2 stimulates the hypothalamus to release gonadotropin-
releasing hormone (GnRH). Gonadotropin-releasing hormone triggers the anterior pituitary 
to release follicle-stimulating hormone (FSH). Follicle-stimulating hormone has its impact on 
the ovaries to recruit and develop follicles. Growth of a follicle includes an increase in the 
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number of granulosa cells – these cells primarily produce and secrete E2.  One of the follicles 
will dominate over the others and continue to grow and differentiate into an immature ovum 
(egg). Estrogen will continue to increase, feedback to the hypothalamus, and stimulate the 
release of leutinizing hormone (LH) from the anterior pituitary. Release of LH further 
stimulates production and secretion of E2 and increases secretion of progesterone. With 
elevated LH and E2, the ovum (egg) is released from the follicle – marking ovulation. When 
the ovum is released, the follicle changes in structure and function to the corpus luteum, 
secreting primarily progesterone. The corpus luteum continues secreting E2 and progesterone. 
If the egg is not fertilized, the elevated E2 and progesterone levels feedback to the 
hypothalamus and inhibit further secretion of GnRH. Without FSH and LH the corpus luteum 
regresses, reducing E2 and progesterone levels eventually leading to menses and the 
beginning of a new cycle. Theoretical E2 fluctuation throughout the menstrual cycle is 
present in Figure 1.   
Once E2 is secreted, it travels throughout the blood on transport proteins (Ruggiero & 
Likis, 2002; Williams & Larsen, 2003). The low molecular weight and carbon backbone of 
E2 allow it to easily move across a cell membrane (Ruggiero & Likis, 2002; Williams & 
Larsen, 2003). In the cytoplasm, E2 binds to a receptor. Once bound, the E2 receptor complex 
moves toward the nucleus where it will stimulate DNA transcription of a particular gene 
sequence to elicit a desired response (Ruggiero & Likis, 2002). Additionally, some cells 
house E2 receptors on the cell membrane thereby allowing E2 to bind at the surface and 
trigger cascade of signaling pathways to provoke the appropriate response (Levin, 2002). The 
magnitude of these responses is dependent of the bioavailability of the hormone and the 
affinity of the receptor (Ruggiero & Likis, 2002).  
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Figure 1: Typical fluctuation of E2 throughout an average 28-day menstrual cycle (adapted 
from Williams & Larsen [2003]). 
 
Two main forms of receptors exist: alpha (α) and beta (β) receptors (Enns & Tiidus, 
2010; Ruggiero & Likis, 2002). Both receptors are present on reproductive tissues, 
vasculature, muscle, brain, and bone (Ruggiero & Likis, 2002). Alpha-receptors are also 
housed on the liver and kidneys, while β-receptors are located within the gastrointenstinal 
and urinary tract (Ruggiero & Likis, 2002). Estrogen has a multitude of actions other than 
female reproductive development; Table 2 highlights some of the non-reproductive actions of 
E2.  
Additionally, E2 receptors have been found on the surface of immune cells including 
T and B lymphocytes, monocytes, and macrophages – all of which perpetuate pro-
inflammatory cytokine production (Bouman et al., 2005; Bird, Karavitis, & Kovacs, 2008). It 
is believed that E2 exerts its influence on the transcription factor associated with immune cell 
gene expression, nuclear factor kappa B. (NF-KB) (McKay & Cidlowski, 1999). When 
stimulated, NF-KB promotes transcription of gene sequences known to stimulate growth, 
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development, propagation of immune cells, including IL-1β and IL-6 (McKay & Cidlowski, 
1999).   
Table 2: Non-reproductive actions of E2 
Tissue Action Result 
Bone Inhibits osteoclasts by modulating IL-6 production and secretion  
Reduces break down of bone - 
preserving bone mineral density 
Increase nitric oxide production Improves vasoreactivity of blood 
vessels and reduces prevalence of 
atheroscerlosis by reduced platelet 
aggregation and leukocyte adhesion 
Increases HDL through 
suppression of hepatic lipoprotein 
lipase at liver, adrenal gland, 
testes, and ovary 
Removes excess lipid on and around 
arterial walls, carrying the lipid to 
the liver for excretion or to the 
adrenal gland, testes, or ovary for 
production of steroid hormones 
Cardiovascular 
Decreases LDL through up-
regulation of hepatic LDL 
receptors 
Reduces the amount of fat deposit 
within the arterial wall thereby 
perpetuate atherosclerosis 
Inhibits gene expression of 
myostatin which regulates muscle 
growth and development  
Suppresses muscle wasting effects of 
myostatin, thereby preserving the 
integrity of muscle tissue  
Stabilizes cell membrane – 
reducing calcium influx thereby 
inhibiting stimulation of proteases, 
enzymes associated with muscle 
break down 
Reduces likelihood of muscle 
damage and degradation 
Shares similar chemical structure 
to antioxidants – decreasing 
oxidation of LDLs 
Protects cells from damage 
Muscle 
Increases activation and 
maturation of satellite cells post 
exercise 
Promotes muscle growth and repair 
Enns & Tiidus, 2010; Gueda et al., 1996; Horowitz, 1993; Jones, Schmidt, Pickard, 
Foxworthy, & Eacho, 2002; Kameda et al., 1997; Mikkola & Clarkson, 2002; Ruggiero & 
Likis, 2002; Walsh et al., 1991; Zhu et al., 2002  
Influence of Estrogen on Cytokines at Rest 
Estrogen receptors are known to be present on cytokine producing cells; however, the 
research on the influence of menstrual cycle phase, as determined by E2 levels, on cytokine 
production is conflicting. Some studies suggest elevated cytokine production with elevated 
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E2, others say E2 inhibits production, and a few have reported no change in production across 
the menstrual cycle. These studies are discussed below. 
The following section will be organized into two subsections on E2’s influence: IL-1β 
and IL-6. Within each of these subsections studies with similar outcomes will be discussed 
collectively. Additionally, many studies generally refer to menstrual cycle phases, not 
hormonal conditions. For ease of comparison in the following sections, hormonal 
concentration status will be used: low E2 hormonal condition (LE) refers to the midfollicular 
phase, while high E2 hormonal condition (HE) refers to the midluteal phase of the menstrual 
cycle.  
Interleukin-1β 
 A majority of studies suggest elevated resting IL-1β levels during the LE condition. 
Cannon and Dinarello (1985) assessed IL-1β in five women during both the LE and HE 
hormonal conditions. The results revealed an approximate 36% increase in IL-1β during the 
HE compared to LE.  
Bouman et al. (2001) studied the immune response across the menstrual cycle in 
fifteen eumenorrheic women. The average age was 30.7 years and cycle length ranged from 
26 - 32 days. Blood samples were taken at the LE and HE points within the cycle. Low E2 
condition was deemed 6-9 days after the onset of menses and HE condition was 
approximately 19 - 25 days after the onset of menses. Estrogen levels were significantly 
different between conditions (LE: 0.57 ± 0.07 vs. HE: 27 ± 0.03 nM, p < 0.05). The 
percentage of immune cells that produce IL-1β were found to be significantly elevated in the 
HE compared to the LE (~77% vs. ~67%), suggesting IL-1β levels are amplified during 
periods of high E2.  
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Willis et al. (2003) reported similar findings compared to Bouman et al. (2001) in ten 
eumenorrheic women aged 24 - 44 years. The average 28-day cycle was divided into two 
phases: pre-ovulation, low E2, (days 8 - 12 from onset of menses) and post-ovulation, high E2 
(days 18 - 22 from onset of menses). The authors found no significant difference between 
conditions for E2 levels (pre: 382 ± 11 vs. post: 399 ± 44 pmol/L); however, they did find a 
significant elevation in IL-1β post ovulation (HE) compared to pre-ovulation (LE) (2.0 ± 0.9 
vs. 0.8 ± 0.3 ng/106 cells, p < 0.05).  
Some studies found no change in IL-1β across varying E2 levels. Al-Haarthi et al. 
(2000) measured the cytokine levels in blood, vaginal cells, and saliva across changing E2 
concentrations. Biological specimens were obtained weekly across two cycles. The LE phase 
was defined as more than 14 days before the next menses and HE phase was deemed 0 - 14 
days before the onset of menses. Blood IL-1β remained the same between hormonal phases 
at less than1 pg/ml. 
Stock, Coderre, McDonald, and Rosenwasser (1989) studied IL-1 in eleven post-
menopausal women, age range 25 – 61 years, following 3 - 9 weeks of oral ingestion of 
0.625 mg E2 daily. Prior to consumption, IL-1 release was 11 ± 4.2 % of the maximum 
release based on monocyte number. Following consumption IL-1 release was 7.8 ± 1.6 % of 
the maximum release based on monocyte number. While the change was non-significant, the 
results trend in a direction suggesting that E2 reduces IL-1 release. A limitation to this study 
is that multiple isoforms of IL-1 exist, some more bioactive than others, and some are the 
antagonist to IL-1β.  
 On the contrary, some researchers have observed IL-1β to be depressed in the HE 
condition compared to LE. Lynch et al. (1994) observed IL-1 changes in eleven women - six 
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oral contraceptive users and five eumenorrheic. Blood samples were drawn 7 - 10 days (LE) 
and 18 - 24 days (HE) after the onset of menses. During sampling day, bloods were obtained 
at 4 time points: 8 AM, 12, 4, and 8 PM. Interleukin-1β secretion remained constant 
throughout the time points assessed in the HE state, ~200 pg/106 cells. Conversely, IL-1β 
secretion was significantly elevated in the LE state and increased during the first three time 
points, peaking at 4 PM ~1000 pg/106 cells, returning to baseline values ~500 pg/106 cells at 
8 PM.  
Morshita, Miyagi, and Iwamoto (1999) found similar results to Lynch despite not 
measuring IL-1β during two distinct hormonal conditions. Twenty-two individuals with an 
average age 23.6 years were recruited, eleven of which were women. Blood was analyzed for 
all isoforms of IL-1 as well as E2 and progesterone. Results showed with increasing amounts 
of E2 a corresponding decrease in IL-1β production with a threshold E2 concentration of 0.04 
ng/ml necessary to warrant a significant reduction. Normal concentration of E2 in a HE state 
is significantly greater than the 0.04 ng/ml seen in Morshita’s study to inhibit IL-1β; 
suggesting E2, in fact, suppresses IL-1β.  
Interleukin-6 
 A majority of studies have found attenuated IL-6 levels during periods of HE. For 
example, Angstwurm et al. (1997) studied five women throughout two menstrual cycles to 
determine if cytokines fluctuated with E2 and progesterone. Their age ranged from 22 - 34 
years and the average cycle length was 28 days. Bloods were sampled seven times 
throughout one cycle: 3, 4, 5, 10, 14, 21, and 28 days after the onset of menses. Interleukin-6 
was significantly elevated in the LE compared to HE phase (LE: 1050 fg/ml vs. HE: 600 
fg/ml, p < 0.009).  
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Berg et al. (2002) found comparable results in post-menopausal women. With 
menopause, E2 production significantly declines. Seventeen post-menopausal women, aged 
52 - 57 years, were divided into two groups: E2 treatment (n = 10) and placebo (n = 7). The 
treatment group received 50 µg of E2 transdermally for 12 weeks. The results indicated IL-6 
was significantly reduced in the treatment group at 12 weeks with no change in the placebo 
group. These results further support the claim IL-6 is inhibited by E2.  
Some have found no significant changes in IL-6 to varying levels of E2 throughout 
the menstrual cycle; however, the results of these studies are not entirely conclusive. Chiu et 
al. (2000) studied the influence of parathyroid hormone and E2 on IL-6 production with 
respect to bone resorption in 20 premenopausal women aged 20 - 40 years. Bloods were 
tested three days a week through an entire cycle starting on day three after the onset of 
menses, cycle length ranged from 24 - 34 days. Estrogen concentration was significantly 
different between hormonal conditions (HE: 100 pg/ml vs. LE: 50 pg/ml). Interleukin-6 
concentration was slightly lower at 1.49 pg/ml in the HE compared to 1.66 pg/ml in the LE. 
Additionally, an inverse correlation between parathyroid hormone and E2 was observed (r = -
0.292, p = 0.002) – parathyroid hormone is positively correlated with IL-6 (r = 0.063, p = 
0.027), implying E2 could have a negative correlation with IL-6.  The author’s proposed the 
mechanism for E2 to exert its influence is on the promoter region of the IL-6 gene sequence, 
inhibiting stimulation of the promoter.  
Schwartz, Schafer, and Bode (2000) compared the relationship between E2 and 
cytokine production in men, eumenorrheic women, and postmenopausal women not 
receiving hormone replacement therapy. For the eumenorrheic women, IL-6 was assessed 2-
6 days after the last day of menses (LE) and 2-6 days before the onset of the next menses 
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(HE). While an insignificant reduction in IL-6 was observed between conditions (LE: 24.2 ± 
4.6 vs. HE: 17.9 ± 3.2 pg/1000 adherent cells), a significant reduction in IL-6 was found in 
the eumenorrheic women during the HE state compared to men and post-menopausal 
women. Both men and post-menopausal women produce less E2 compared to eumenorrheic 
women. The authors implied their findings support the concept that E2 may inhibit IL-6 
production. Further support for E2 anti-inflammatory nature was seen from the other findings 
in this study, as there was a significant reduction in TNF-α, a pro-inflammatory cytokine 
known to stimulate IL-6 secretion, during HE periods.  
Jilma et al. (1997) hypothesized the IL-6 response would mirror that of IL-1β 
throughout the menstrual cycle since IL-1β stimulates IL-6 secretion and production. 
Eighteen eumenorrheic women, average age 26 ± 3 years, were studied. The average 
menstrual cycle length was 29 days. The LE condition blood samples were taken 7 days after 
the start of menses. Subjects were given an at home ovulation kit. Nine days following a 
positive ovulation test another blood sample was taken, marking the HE condition – 
approximately 5 days before the onset of menses. Estrogen concentration nearly tripled from 
the LE to HE (LE: 145 pmol/L vs. 392 pmol/L); however, IL-6 concentration remained 
steady at 0.68 pg/ml throughout both hormonal conditions.  
Al-Haarthi et al. (2000) had similar findings in ten eumenorrheic women. The 
purpose of their research was to measure immune constituents throughout the menstrual 
cycle within different specimens including blood, vaginal cells, and saliva. Biological 
specimens were obtained weekly across two cycles. The LE phase was defined as more than 
14 days before the next menses and HE phase was deemed 0 - 14 days before the onset of 
menses. Interleukin-6 concentration did not change between the phases (<1 pg/ml).  
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Willis et al. (2003) reported opposite findings compared to Chiu et al. (2000) and 
Schwartz et al. (2000). Interleukin-6 was assessed both pre (LE) and post (HE) ovulation 
(pre: days 8 - 12; post: days 18 - 22 from onset of menses) in ten eumenorrheic women aged 
24 – 44 years (Willis et al., 2003). While IL-6 was lower pre-ovulation compared to post-
ovulation (pre: 18.1 ± 5.7 vs. post: 35.1 ± 11.0 ng/106 cells) the difference was not 
statistically significant.  
Konecna et al. (2000) studied the fluctuation of IL-6 across a normal menstrual, 26 -
28 days, in five non-oral contraceptive using women (average age = 31 years). Estrogen 
concentration followed the theoretical physiological model throughout the cycle: increase to 
ovulation, slight drop, followed by a second surge, and another drop to initiate menses. The 
authors found IL-6 significantly elevated during ovulation and late luteal (1.9 pg/ml) 
compared to follicular (1.5 pg/ml). This conflicting result, compared to previous research, 
could be a function of hormonal condition determination. Konecna et al. (2000) observed 
elevated IL-6 levels during ovulation and late luteal phase of the menstrual cycle. Late luteal 
is generally marked by a reduction in E2 in order to stimulate menses (Williams & Larsen, 
2003); thereby if E2 levels are lower at this point it would actually by in line with previous 
research (Angstwurm et al., 1997; Berg et al., 2002). Konecna et al. (2000) reported E2 
concentration during late luteal was ~ 300 pmol/L, more than two times lower than the peak 
E2 concentration observed (~ 700 pmol/L), Additionally, within Konecna’s study, IL-6 
fluctuates dramatically post ovulation and throughout the luteal phase, making it difficult to 
find a definitive point of reference.  
In summary, basal E2 has an influence on resting IL-1β and IL-6 across varying E2 
levels; however, the nature of the relationship is inconsistent. Despite the inconsistency, this 
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fluctuation observed in IL-1β and IL-6 at rest when E2 changes warrant the question of 
whether or not a similar response is present during and following exercise since exercise 
influences both E2 and cytokines. 
Estrogen and Muscle Damage 
 As previously stated, muscle damage is a form of tissue trauma and this tissue trauma 
can provoke an immune response. The following section reviews studies looking at the 
relationship between E2 and biological markers of muscle damage in response to exercise. 
Tiidus et al. (2001) studied the influence of E2 on membrane damage in animals 
following exercise. Forty-eight rats were ovarectomized and randomly assigned to one of 
four treatment groups: unexercised + placebo (UP), unexercised + 25 mg E2 (UE), 60-
minutes exercised + placebo (EP), 60-minutes exercised + 25 mg E2 (EE). Estrogen 
concentration was 10 - 20 times higher in the E2 supplemented group comparatively. Creatine 
kinase (CK) was significantly lower in UE versus EE. Following exercise, CK levels in EP 
were almost twice that of EE. These results suggest E2 protects against muscle damage. 
Additionally, neutrophil count, myeloperoxidase activity, and calpain activity in the muscle 
were significantly lower in EE compared to EP. All three of these measures are associated 
with destruction of tissue; therefore, these findings support that E2 appears to reduce the 
likeliness of muscle damage.  
Kerksick et al. (2008) analyzed the effect of E2’s effect on muscle injury in 
recreationally active individuals following eccentric exercise. Eight men and women, aged 
21 years, were recruited for the study. Women performed the exercise bout during a HE 
phase. The HE time point revealed the greatest difference in E2 (men: 9.5 vs. women: 113.8 
pg/ml). The treatment exercise treatment was 7 sets, 10 repetitions on an isotonic resistance 
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knee extension machine focusing on the eccentric contraction. Markers of muscle injury was 
recorded before, 6-hours post, and 24-hours post exercise. Results showed the bax/bcl-2 ratio 
was reduced in women compared to men following exercise, possibly the result of women 
having a significant increase in bcl-2. The bax/bcl-2 ratio explains the regulation of cell 
apoptosis; bax protein promotes cell death, while bcl-2 protein inhibits cell death. 
Additionally, cell death was significantly greater in men at all time points and gradually 
increased from resting values, while cell death did not change in women. Cell death occurs in 
response to trauma in an attempt to clear away damaged or infected tissue; the authors 
concluded these results suggest less injury occurs in women as a result of E2 protecting cells 
against insult.  
 Carter et al. (2001) examined the influence of E2 on muscle damage following 30 
minutes of downhill running. Twenty-seven fit women (VO2max ~ 43 ml/kg/min) were 
recruited to participate; ten were non-oral contraceptive users tested during their LE phase (6 
– 10 days after start of menses) and seventeen were oral-contraceptive users tested during 
their HE phase (22 – 25 days after start of menses). Estrogen levels were significantly 
different between groups (LE: 112.4 ± 56.9 vs. HE: 269.8 ± 62 pg/ml). Creatine kinase 
activity was measured before, immediately post, 24-hours, 48-hours, and 72-hours following 
exercise. Twenty-four hours following exercise, CK was higher in the LE compared to HE; 
by 72-hours the difference was significant. 
 Collectively, the studies discussed above support the notion that exercise induces 
muscle damage. Furthermore, the magnitude of damage appears to be attenuated by the 
presence of E2, indicating a protective role of E2.  
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Estrogen and Immune Response to Exercise 
Few studies have directly looked at the influence of menstrual cycle on cytokines 
following exercise. Timmons, Hamadeh, Devries, and Tarnopolsky (2005) conducted a sudy 
observing the effect of gender and menstrual cycle phase on immune parameters following 
prolonged exericse. Twelve women (6 oral contraceptive users) and eleven men were 
recruited for the study. The age of the subjects ranged from 19 – 25 years. Subjects 
completed a VO2max test on a cyle ergometer; VO2max averaged 54 ml/kg fat free mass/min 
and 56 ml/kg fat free mass/min for women and men, respectively. The treatment protocol 
was a 90-minute cycling bout at 65% VO2max during both the LE and HE hormonal 
condition (aproximately 9 and 20 days after onset of menses). Blood samples were obtained 
before the start of exercise and immediately post exercise. Estrogen was higher in HE 
comapred to LE (361 ± 263 vs. 195 ± 188 pmol/l, comparitively); however the difference 
was not statistically significant, possibly the result of large variance. Resting IL-6 levels were 
similar across both genders and hormonal conditions (~ 2.0 pg/ml). Immediately following 
exercise, IL-6 was slightly higher in both absolute values and percent change in the LE state 
compared to men and the HE condition, but again the difference was not statistically 
significant. Interleukin-6 increased by 285% in the LE compared to 235% in men and 215% 
in the HE. These results imply that E2 is not a significant modulator of the cytokine response 
to exercise.  
Conversely, Northoff et al. (2008) found that pro-inflammatory cytokines genes were 
up-regulated during the HE phase of the cycle compared to the LE phase. The authors were 
studying gene expression of immune cells with respect to gender and varying E2 
concentration across the menstrual cycle. Twelve men and nine non-oral contraceptive using 
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women were recruited. Age ranged from 25.4 - 36.4 years. Men were significantly more 
physically fit compared to women; training volume and running speed at anaerobic threhold 
were significantly higher for men compared to women (61 vs. 38 kilometers/week; 13.9 vs. 
11.7 kilometers per hour, respectively). Subjects completed two 60-minute running trials at 
93% of their anaerobic threshold running speed: for women, one during the LE condition and 
the other during the HE condition (day 10 and 25 after the start of menses). Blood was 
measured one hour prior to the start and immediately following cesation of exercise. 
Estrogen was non-detectable in men and non-significantly higher in the HE comapred to the 
LE (491 vs. 370 pmol/l) in the women. Baseline IL-6, classified as anti-inflammatory 
according to the authors, genes were elevated in the HE state and suprressed in the LE. 
Following exercise, IL-6 along with IL-1ra gene expression were significantly 
downregulated in the HE phase and trending toward being significantly upregulated during 
the LE phase, suggesting a pro-inflammatory response following exericse during times of 
HE. The authors suggest that these results may be confounded by the fact that baseline IL-6 
were not similar between conditions, e.g. IL-6 gene expression was supressed in LE 
condition and enhanced in the HE. Additionally, only gene expression was observed. 
Alteration of gene expression does not necessarily translate to an increase in circulating 
cytokine levels.  
The findings of these two studies suggest IL-6 is upregulated during the LE condition. 
However, Timmons et al. (2005) did not reach significance. Additionally, Northoff et al. 
(2008) classified IL-6 as an anti-inflammatory cytokine and saw additional anti-inflammatory 
genes down-regulated in the HE condition, suggesting HE is more pro-inflammatory in 
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nature. These limited number of studies suggest additional research in this area are necessary 
to clearly define the relationship between E2 and cytokines.  
Summary 
In summary, cytokines are messenger proteins released from immune and non-
immune related cells (Corwin, 2000; Moldoveanu et al., 2001). These messengers are 
released in response to stress, infection, trauma, and exercise – stimulating further responses 
to either upregulate (pro-inflammatory) or suppress (anti-inflammatory) immune action 
(Corwin, 2000; Moldoveanu et al., 2001; Pederson et al., 1998). Generally, pro-inflammatory 
cytokines such as IL-6 and IL-1β are released immediately following infection and trauma 
(Corwin, 2000; Moldoveanu et al., 2001). Along with upregulating cells associated with 
humoral immunity (e.g. B-cells, anti-body formation, acute phase protein production), IL-1β 
and IL-6 influence cardiovascular tissue, muscle, and bone as well (Abbas & Litchman, 
2003; Diehl & Rincon, 2000; Faist, Schinkel, & Zimmer, 1996; Smith, 2004; Corwin, 2000; 
Moldoveanu et al., 2001). Shortly following, anti-inflammatory cytokines are secreted in an 
attempt to maintain immune reaction within a narrow window (Corwin, 2000; Moldoveanu et 
al., 2001). Unregulated immune responses can lead to autoimmune diseases.  
Previous research has shown elevated IL-1β and IL-6 levels following exercise. 
Mode, duration, and intensity of exercise influence the elicited response (Pederson et al., 
1998). Eccentric exercise appears to elicit a greater increase in pro-inflammatory cytokines 
compared to concentric exercise (Bruunsgaard et al., 1997; Nieman et al., 1998). It also 
appears there is a duration dose response with respect to the magnitude of the pro-
inflammatory response.  That is, the longer the duration of the exercise session the more 
pronounced the response (Brenner et al., 1999; Ostrowski et al., 1999; Nieman et al., 1998; 
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Nieman et al., 2001). The mechanism behind this increase is not entirely understood. Some 
possible mechanisms include increased muscle damage, endotoxemia, and or increased 
production of reactive oxygen species (Bruunsgaard et al., 1998; Pederson & Hoffman-
Goetz, 2000; Kendall & Eston, 2002).  
A limitation to the aforementioned studies is the population is primarily males. 
Nieman et al. (2001) studied both males and females following exercise and found no 
influence of gender on cytokine response. Conversely, Edwards et al. (2003) reported a 
significant difference between men and women following intense exercise. Unfortunately, 
Nieman et al. and Edwards et al. did not take hormonal status into consideration.  
In studies measuring cytokines across varying E2 levels, basal E2 appears to have an 
influence on resting IL-1β and IL-6; however, the nature of the relationship is inconsistent 
(Angstwurm et al., 1997; Berg et al., 2002; Chiu et al., 2000; Konecna et al., 2000; Schwartz 
et al., 2000). The variance in conclusions could be the result of small sample sizes, improper 
phase determination, timing of blood samples, or assay sensitivity.  Despite the conflicting 
reports, an influence of E2 on the immune system does exist at rest.  
Few have examined the relationship following exercise. Timmons et al. (2005) 
observed a greater increase in IL-6 during the LE condition compared to HE; however, the 
result was not statistically significant. Conversely, Northoff et al. (2008) saw an upregulation 
of IL-6 genes in the LE following exercise; however, IL-6 in their study was classified as an 
anti-inflammatory. These are the only two known studies to assess the influence of changing 
E2 levels on immune response to exercise. The lack of available information suggest 
additional studies should be carried out to further our understanding of the relationship.  
 
 
 
CHAPTER III 
Methodology 
The study required seven visits for each subject. On separate days subjects performed 
an exercise test on a treadmill to determine VO2max, two 90-minute running bouts at 
approximately 70% of their VO2max, and had blood drawn before, immediately post, 24-
hours post, and 72-hours post exercise for each 90-minute running bout. The 90-minute 
running bout and subsequent blood draws occurred at two specific hormonal conditions: low 
E2 (LE) and high E2 (HE). The blood samples were used to determine E2, IL-6 and IL-1β 
concentration, and CK activity.  
Subjects 
Sample size was determined using expected responses of the IL-6 cytokine to 90-
minute bouts of exercise based from previous research data. A α level of 0.05 required a total 
of 10 healthy, highly trained women for a statistical power of 0.8. Women between the ages 
of 18-30 were recruited. Subjects had maintained eumenorrheic status, defined as a menstrual 
cycle consistently lasting 24-35 days. A minimum VO2max of approximately 45 ml/kg/min 
was necessary to participate in the study. Completion of at least one half-marathon, or a race 
of an equivalent distance under 2 hours 30 minutes was required for participation. No major 
injuries that could impact performance or the ability to participate in physical activity within 
6 months prior to testing were necessary. If an injury was reported within 6 months prior to 
testing, the subject had to be completely recovered as noted by her physician. Subjects had a 
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current minimum training volume of 3-5 days a week, 45-120 minutes per session of aerobic 
activity for inclusion.  
Women who were knowingly pregnant or became pregnant during the study were 
excluded. Amenhorrheic (absence of menstruation) or Oligomenorrheic (irregular cycle) 
women were excluded. Participants who used substances known to alter immune response 
(e.g. NSAIDS) the week before each 90-minute exercise session or became ill with immune 
responding conditions (i.e., colds, respiratory infections…etc.) were excluded. If any 
contraindications to exercise highlighted by ACSM discovered during the medical history 
interview and physical examination or abnormal rhythms were found on their 12-lead 
electrocardiogram the subject was excluded and encouraged to consult her physician.  
Instrumentation: 
Subject height was measured using a stadiometer (Perspective Enterprises, Portage, 
MI).  Mass was measured using a mechanical scale (Detecto, Webb City, MO). A Lange 
skinfold caliper (Model 68902, Cambridge Scientific industries, Inc., Cambridge, MA) was 
used to assess body composition. A refractometer (Milton Roy, Rochester, NY) was used to 
assess hydration status (urine specific gravity) prior to the prolonged treadmill running bout. 
The running bout was performed on a Quinton MODEL # Q65 treadmill (Cardiac Science 
Corporation Bothell, WA). A Polar heart rate monitor was used to monitor heart rate 
throughout the exercise bout (Polar Electro Inc., Lake Success, NY). Respiratory gas 
exchanges were measured using Parvo Medics TrueMax® 2400 metabolic System (Parvo 
Medics, Salt Lake City, UT, USA). The Borg scale was used to determine ratings of 
perceived exertion [RPE] (American College of Sports Medicine, 2006). Hematocrit was 
determined using microcapillary tubes (Fisher Scientific International Inc., Hampton, NH), 
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cortiseal (Krakeler Scientific Inc., Albany, NY), Adams MCHT II microhematocrit 
centrifuge (Beckton Dickinson, Frankin Lakes, NJ), and an International Microcapillary 
Reader (International Equipment Company, Needham Heights, MA). Hemoglobin was 
analyzed using the stat-site WT-9” hemoglobin meter (Stanbio Laboratory, Boerne, TX). 
Blood separation consisted of centrifuging blood at 3000 X g for 15 minutes in an IEC 
Centra-8R refrigerated centrifuge (International Equipment Company, Needham Heights, 
MA). The plasma was aliquoted and frozen at -80 oC. Estrogen levels were determined using 
an enzyme-linked immosorbent assay [ELISA] (Abnova, Walnut, CA). Creatine kinase 
levels were analyzed using a spectrophotometric assay (Stanbio Laboratory, Boerne, TX). 
The cytokines, IL-6 and IL-1β, were determined using an ELISA (Biolegend, San Diego, 
CA). All ELISA plates were analyzed via Finstruments microplate reader (Model 310, MTX 
Lab System Inc., Vienna, VA) and Spectra Software (MTX Lab System Inc., Vienna, VA).  
Protocol 
Orientation/Familiarization Session 
A prescreening questionnaire concerning menstrual status and training status was 
administered over the phone to determine if a potential subject met the inclusion criteria (see 
Appendix A). If so, the subject was then scheduled to come to the Applied Physiology 
Laboratory at University of North Carolina at Chapel Hill. Explanation of the study protocol, 
schedule, inherent benefits, and potential risks were discussed with subject, followed by their 
signing an informed consent statement (Appendix B). The subject completed a medical 
history questionnaire and underwent a physical examination and 12-lead electrocardiogram 
(Appendices C & D). Height and mass were obtained and the subject outfitted with a heart 
rate monitor. Next, the subject rested for 10 minutes to obtain a resting heart rate. A modified 
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Astrand protocol was administered to determine VO2max. Heart rate and respiratory gases 
were monitored continuously throughout the test. Heart rate was recorded at the end of each 
minute of the test. Rating of perceived exertion was recorded at the end of each stage. 
Participants were provided verbal encouragement throughout the test. At the completion of 
the test, subjects were permitted to recover actively or passively. Once heart rate was less 
than 100 bpm and no adverse post-exercise responses observed, the subject was allowed to 
leave the lab.  
Successful attainment of VO2max was defined as: a decrease, plateau, or less than 
0.15L/min increase in VO2 with subsequent increase in workload, a respiratory exchange 
ratio greater than 1.1, and RPE score greater than 18. If all criteria were not met the test was 
deemed a VO2peak test. The maximal VO2 attained was used to determine running speed for 
the specific menstrual phase running bout for each individual subject. Estimated running 
speed to require 70% of VO2max was determined through a linear regression equation 
plotting steady state VO2 against subsequent running speed. 
Hormonal Condition Determination 
The subject informed the researcher at the start of menses, denoted as day 1. 
Approximately 7 ± 2 days after the start of menses marked LE (Williams & Larsen, 2003). 
Approximately 22 ± 2 days after the start of menses marked HE (Williams & Larsen, 2003). 
The above was based on an average 28-day cycle. For shorter or longer menstrual cycles (as 
determined from phone screening), hormonal states were calculated based on the 
proportionality of the average 28-day cycle (e.g. HE phase is approximately day 22 of a 28-
day cycle [22/28=0.79], for a 32-day cycle HE would be approximately day 25 [32 x 0.79] of 
the menstrual cycle). Scheduling of the prolonged treadmill running bout corresponded with 
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the subject’s LE and HE hormonal conditions (± 2 days).  Desired hormonal status was 
confirmed later with E2 measurements. 
Prolonged, Treadmill Running Bout  
Twenty-four hours prior to the prolonged running bout session, the subject was 
instructed to refrain from exercise, consume plenty of water, and eat high carbohydrate 
foods. The subject reported to the laboratory at the same time of day during the specified 
phase of the menstrual cycle. Upon arrival, a urine sample was collected from the subject to 
determine hydration status. If a subject’s specific gravity was below 1.030 cc3 she was 
deemed dehydrated, did not complete the prolonged running bout, was encouraged to 
consume plenty of fluids, and rescheduled for a later date. If the specific gravity was above 
1.030 cc3 the subject was weighed, fitted with a HR monitor, and asked to rest in the supine 
position for 10 minutes. At the completion of the 10-minute rest period, resting HR was 
recorded and a blood sample was drawn via venipuncture by a nationally certified 
phlebotomist, placed in K3-EDTA blood collection and SST sterile tubes, and immediately 
put on ice. The blood sample was used to confirm menstrual cycle status and resting IL-6, IL-
1β, E2, and CK levels. Next, the subject was moved to the treadmill and fitted for a 
mouthpiece. The subject sat quietly for 4 minutes as respiratory gases were collected to 
determine resting VO2. The subject warmed up for 10 minutes: 5 minutes of easy walking on 
the treadmill followed by 5 minutes of stretching. During the warm-up, the subject practiced 
putting the mouthpiece in and out of their mouth while moving, as she had to do so 
periodically during the 90-minute running bout. Following the warm-up, the subject ran on a 
treadmill at a speed (0% grade) to elicit 70% VO2max as estimated from the VO2max test. At 
6 minutes, 26 minutes, 56, and 86 minutes the subject returned to the mouthpiece and 
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respiratory gases were recorded for four minutes. The purpose of gas collection was to ensure 
appropriate intensity and make adjustments in running speed if necessary. Heart rate and 
RPE were recorded during the last 10 seconds of minute 9, 29, 59, and 89 of the running 
bout. Throughout the running bout the subject drank water ad libitum, listened to music, and 
had a fan to keep cool.  
At the completion of exercise, a blood sample was drawn following the same 
procedure, placed in K3-EDTA blood collection and SST sterile tubes, and immediately 
placed on ice. This blood sample was analyzed for IL-6 and IL-1β concentrations. After 
blood collection the subject cooled down. Once HR was below 100 bpm the subject was 
released from the laboratory.  
Follow-up Blood Draws 
At 24 and 72 hours post running bout the subject reported to the laboratory for 
additional blood draws. The subject rested in the supine position for 10 minutes. Blood 
samples were obtained following the same blood draw procedures. These blood samples 
were analyzed for IL-6 and IL-1β concentrations and CK activity. During the 72 hours of 
recovery from the running bout subjects were asked to refrain from performing no more than 
30 minutes of light physical activity. The subject repeated the aforementioned protocol 
during both their LE and HE phase.  
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Figure 2: Prolonged treadmill running bout timeline. 
  43 
Blood Analysis 
Hematocrit 
Resting and immediate post exercise hematocrit values were determined for each 
running bout. Whole blood was drawn into a heparin treated microcapillary tube, sealed, and 
placed in a mircohematocrit centrifuge for 3 minutes at 10,000 rpm.  Next, the microcapillary 
tube was placed on a hematocrit wheel; the proportion of red blood cells within blood was 
determined. Measures were performed in triplicates and averaged for each blood sample to 
be used in plasma volume shift determinations.   
Hemoglobin 
Resting and immediate post exercise hemoglobin values were determined for each 
running bout using a handheld analyzer. Twenty-five microliters of whole blood was pipetted 
onto on a slide and analyzed instantly. Measures were performed in duplicates and averaged 
for each blood sample to be used in plasma volume shift determinations.  
Plasma Volume 
To account for changes in plasma volume that occur as a result of exercise, plasma 
volume shifts were calculated with hemoglobin and hematocrit levels using the Dill and 
Costill method (Dill & Costill, 1974).  
Estrogen, Cytokines, Creatine Kinase 
The blood samples were centrifuged at 3000 X g for 15 minutes at 4°C to separate the 
plasma. The plasma and serum were aliqouted, placed in cryofreeze tubes, and frozen at -
80°C until later analysis.   
To confirm menstrual phase status, E2 concentrations were measured using an 
enzyme-linked immunosorbent assay (ELISA). Enzyme-linked immunosorbent assays were 
  44 
also used to determine IL-6 and IL-1β concentrations. A spectrophotometric assay was used 
to determine CK activity. Details of these assay procedures are in the Appendix F. Triplicate 
determinations were executed for standards. Duplicate determinations were performed for all 
of the above assays.  
Statistical Analysis: 
SPSS version 18 (Chicago, IL) was used to analyze data. The alpha level was set at p 
< 0.05 a priori. Values are reported as means ± standard deviations (SD).  
To examine E2 concentration between hormonal conditions a one way repeated 
measures analysis of variance (ANOVA) was performed. The analysis was used to determine 
whether or not the appropriate difference in E2 between LE and HE was elicited.  
To ensure the subjects were in the same physiological state prior to each prolonged 
running bout, pre-exercise measurements (e.g. specific gravity, weight, CHO consumption, 
resting HR, and resting VO2) were evaluated using separate repeated measures ANOVA.  
Cardiorespiratory measurements (i.e., HR, VO2, and RPE) recorded during the 
running bout were assessed using separate one-way repeated measures ANOVA. A 
Bonferroni procedure was administered for post hoc testing if a significant F-ratio was found 
in an ANOVA. These analyses were performed to establish if subjects were working at a 
steady state throughout each of the prolonged bouts and if the intensity were the same 
between the two trials.  
To determine if any muscle damage was amassed as a result of the prolonged running 
bout CK activity was assessed using a 2 x 3 (menstrual cycle phase x blood sample time: pre-
exercise, 24-hr post, 72-hr post) within-subjects ANOVA followed by bonferroni adjusted 
post hoc testing for any significant F-ratio found. To determine whether or not the magnitude 
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of change in CK activity was different between phases, percent change scores were 
calculated. Percent changes scores were calculated for the change in CK from rest to 24-
hours post exercise and rest to 72-hours post exercise. The percent change scores were 
calculated for both menstrual cycle phases for a total of four values. All changes scores were 
calculated using the following equation: percent change = [(post exercise – pre-exercise)/pre-
exercise] x 100. A 2 x 2 repeated measures ANOVA was conducted with bonferroni post hoc 
testing for any significant F-ratio found in the ANOVA.  
To assess whether or not fluctuations in E2 modulate the IL-6 and IL-1β response 
during exercise, separate 2 x 4 (menstrual cycle phase x blood sampling time: pre-exercise, 
immediate post, 24-hr post, 72-hr post) within-subjects analysis of variance (ANOVA) were 
performed (research questions 1 and 2). A Bonferroni procedure was administered for post 
hoc testing if a significant F-ratio was found in an ANOVA.  
To evaluate if the magnitude of change in cytokine concentration following exercise 
was influenced by hormonal condition, three percent change scores were calculated for IL-6 
and IL-1β for each hormonal condition for a total of six percent change scores. The percent 
change scores calculated for each cytokine were as follows: change in concentration from 
rest to immediately post exercise, rest to 24-hours post exercise, and rest to 72-hours post 
exercise.  A 2 x 3 repeated measures ANOVA was conducted to evaluate the influence of 
menstrual cycle phase on the magnitude of change in IL-6. A Bonferroni procedure was used 
for post hoc testing if a significant F-ratio was found in the ANOVA. 
 
 
 
CHAPTER IV 
Results 
Originally, the goal of the study protocol was to enroll only eumenhorreic women; 
however, given unforeseen challenges in recruitment not enough of these women who met all 
other inclusion criteria could be found. As a result, the study also recruited women currently 
using oral contraceptives (OC) who met the other inclusion criteria. Five eumenhorreic 
women and five OC women completed all aspects of the study protocol, except OC women 
completed only one of the 90-minute running bouts during what was hormonally considered 
LE. For the remainder of the document, the phrase “eumenhorreic women” will refer to the 
collective group of both OC and eumenhorreic subjects recruited into the study.  
Additionally, the study protocol was highly involved requiring repeated trips to the 
laboratory for follow-up blood draws. In some instances, subjects were unable to make it to 
the laboratory resulting in a missed blood sample. In order to maintain the integrity of the 
repeated measures design, SPSS (version 18.0) missing variables analysis function was 
employed to estimate missing data values. This method for using estimated missing values in 
the statistical analysis follows the suggestions published by Linton and Gallo (1975). 
Subject Characteristics 
Twelve highly trained female runners were recruited for this study. Ten of the twelve 
completed the study protocol while two subjects withdrew for personal reasons. All 
participants met the inclusion criteria: maintained normal menstrual cycle, completed a half 
marathon under 2 hours 30 minutes within the last year, no major injuries with the last six 
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months, a minimum VO2peak of 45 ml/kg/min, and trained a minimum of 3-5 days per week, 
45 to 120 minutes per session aerobically. Participant physical characteristics are reported in 
Table 3.  
 Table 3: Participant physical characteristics (n=10) 
Measure Mean ± SD Range 
Age (yrs) 25 ± 4 20 – 29 
Height (cm) 163.8 ± 3.8 158.0 – 171.0 
Body Mass (kg) 58.0 ± 3.6 52.0 – 63.9 
Body Fat (%) 24.5 ± 4.7 19.4 – 35.1 
 
VO2peak Testing 
 All maximal oxygen uptake tests are collectively referred to as VO2peak tests as 
subjects did not unanimously meet all VO2max criteria set forth in the methodology chapter. 
The absolute VO2peak (mean ± SD) measured was 3.20 ± 0.40 L/min (range 2.73 – 3.89 
L/min) which converts to a relative VO2peak of 55.7 ± 3.4 ml/kg/min (range 50.1 – 60.9 
ml/kg/min).  The peak RPE obtained was 18 ± 2 Borg units (range 15 – 20 Borg units) while 
the peak HR was 188 ± 7 bpm (range 174 - 197 bpm). The mean running speed at the 
VO2peak response was 15.7 ± 1.0 km·h-1 (range 14.4 – 17.3 km·h-1). The mean time to reach 
VO2peak during testing was 18.27 ± 1.78 minutes (range 16.07 – 22.00 minutes).  
Hormonal Condition Determination 
 Menstrual cycle length from the previous four months was collected for each subject. 
The menstrual cycle length (mean ± SD) was 29 ± 2 days (range 24 - 34 days). Individual 
menstrual cycle phases were determined using a proportion of the average 28-day menstrual 
cycle as detailed in the methodology chapter. The midfollicular (LE) phase was 8 ± 1 days 
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(range 6 – 9 days) after the onset of menses. The midluteal (HE) phase was 23 ± 3 days 
(range 20 – 26 days) after the onset of menses. The actual days on which the subjects 
performed their prolonged running bouts (90 minutes) was 9 ± 2 days (range 7 – 10 days) for 
LE and 23 ± 3 days (range 19 – 27 days) for HE. 
 Hormonal analysis of resting blood samples for 17β-estradiol (E2) confirmed the 
appropriate menstrual phase and hormonal status (i.e., treatment effect) of the subjects. The 
LE E2 concentration was 53.35 ± 13.33 pg/ml, while the HE E2 concentration was 106.16 ± 
20.55 pg/ml. These concentrations were significantly different [F (1, 9) = 133.907, p < 
0.001].   
Prolonged Treadmill Running Bout 
All subjects followed and complied with pre-session guidelines (see Chapter 3). The 
mean specific gravity was well below the 1.030 cc2 for both LE and HE prolonged running 
bouts, suggesting all subjects were in a euhydrated state prior to running. There was a 
significantly higher specific gravity at LE (1.013 ± 0.0049 cc2) compared to HE (1.004 ± 
.0065 cc2) [F (1, 9) = 8.034, p = 0.02)], but both values were normal. A diet moderately high 
in carbohydrates (CHO) was consumed 24-hours prior to both LE and HE prolonged running 
sessions.  The percent of daily calories from CHO was 53 ± 6% and 57 ± 5% for LE and HE, 
respectively and was not different [F (1, 9) = 3.586, p = 0.091]. Mean body mass at the time 
of the prolonged running bouts at LE and HE were 57.63 ± 3.52 kg and 58.66 ± 2.37 kg and 
did not differ [F (1, 9) = 0.655, p = 0.439].   
 The prolonged running bouts were to be run for 90 minutes at 70% of individual 
subjects VO2peak. All subjects were able to complete each of their 90-minute sessions, and 
the actual running speed was 11.2 ± 0.6 km·h-1, corresponding to an overall VO2 of 2.20 ± 
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0.05 L/min or approximately 67.0 ± 1.6 % VO2peak and was identical for LE and HE 
sessions. No significant differences between estimated and actual VO2 (L/min) were found 
[F (2, 18) = 2.11, p = 0.150].   
 While the exercise VO2 responses were alike between hormonal conditions, the 
absolute VO2 values obtained throughout the prolonged running bouts showed a slight 
increase in effort over time [F (3, 27) = 30.739, p < 0.005] (i.e. main effect; see Table 4).  
Post Hoc analyses revealed a significantly higher absolute VO2 at 30, 60, and 90 minutes 
compared to 10 minutes during the exercise (p = 0.001). Analyses also showed a significantly 
higher mean absolute VO2 at 90 minutes compared to 30 minutes (p = 0.030).  
 Resting HR was slightly, but significantly, lower at LE compared to HE [t (9) = -
2.428, p = 0.038; see Table 4]. Heart rate responses over the running bout were similar 
between hormonal conditions. Heart rate, however, did gradually increase over the course of 
the run in both HE and LE [F (3, 27) = 58.543, p < 0.005] (i.e. main effect; Table 6). Post 
Hoc analyses showed HR was significantly higher at 30, 60, and 90 minutes compared to 10 
minutes during the exercise (p < 0.001). Additionally, results revealed mean HR was 
significantly higher at 60 and 90 minutes compared 30 minutes (p = 0.016; p < 0.001). 
Lastly, mean HR was significantly higher at 90 minutes compared to 60 minutes (p < 0.001).  
 Ratings of perceived exertion measures obtained suggest the perception of effort was 
not the same between hormonal conditions (Table 4). That is, the ANOVA results for RPE 
throughout the prolonged running bouts presented a significant interaction effect for 
hormonal condition and time [F (3, 27) = 9.959, p < 0.001]. Post hoc analyses indicated at 10 
minutes of running RPE was significantly higher in LE compared to HE (p = 0.013). At 30 
and 60 minutes, however, RPE was significantly higher in HE compared to LE (p = 0.045, p 
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= 0.015). Additionally, perceived effort gradually increased over time for both LE and HE 
conditions [F (3, 27) = 57.756, p < 0.001].  Post hoc analyses showed RPE were significantly 
higher at 30, 60, and 90 minutes compared to 10 minutes during the exercise (p < 0.001).  
Also, the RPE was significantly higher at minutes 60 and 90 compared to minute 30 (p = 
0.003, p = 0.004).  
 Plasma volume decreased over the entire 90-minute running bout. Mean plasma 
volume decreased by -12.3 ± 5.8 % and -9.3 ± 4.6 % at LE and HE, respectfully; conversely, 
these plasma volume shifts observed were not significantly different between hormonal 
conditions [F (1, 9) = 2.570, p = 0.143]. 
Blood Responses to Prolonged Running Bout  
 Resting, 24-hour, and 72-hour CK activity are reported in Table 5. The statistical 
analysis indicated a significant interaction effect for hormonal condition and time [F (2, 18) 
= 4.310, p = 0.030]. Post hoc revealed resting CK activity was not significantly different 
between LE and HE (p = 0.573). Twenty-four hours following the prolonged running bout, 
CK activity tended to be higher in LE than HE (p = 0.079); and by 72-hour, CK responses 
were significantly higher in LE comparative to HE (p = 0.026). Conversely, when assessing 
the percent changes from rest in CK only a main effect for hormonal condition was found [F 
(1, 9) = 7.361, p = 0.024; see Table 5].  The percent change for CK from rest following 
exercise was significantly higher for the LE compared to HE.  
 Interleukin-6 responses to the prolonged running bout are presented in Table 6. 
Statistical analysis indicated no interaction effect for IL-6 concentration; however, significant 
main effects for hormonal condition [F (1, 9) = 10.344, p = 0.011] and for time existed [F (3, 
27) = 12.029, p = 0.002]. Relative to hormonal status, IL-6 concentration was significantly 
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higher for the LE session compared to the HE session. Relative to time, post hoc analyses 
revealed IL-6 was significantly elevated from rest immediately (IP) following exercise (p = 
0.016). Moreover, IL-6 concentration was significantly lower at 72-hour post exercise 
compared to IP (p = 0.012).  
Concomitantly, analysis for the percent changes from rest in IL-6 revealed only a 
significant main effect for time [F (2, 18) = 13.043, p = 0.001; see Table 6]. Post hoc 
analyses indicated the change (increase) in IL-6 observed at IP following the prolonged 
running bout was greater compared to the change from rest observed at 72-hour post exercise 
(p < 0.001).   
Due to procedural problems and assay complications, detectable levels of IL-1β were 
unobtainable for the blood samples collected in this study. Therefore, no IL-1β values are 
reported.  
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Table 4: Mean (±SD) VO2, HR, and RPE for prolonged running bouts for LE and HE 
hormonal conditions.   
 
An “x” indicates no value was recorded for the particular time point. * Indicates a 
significantly lower VO2 compared to 10, 30, 60, and 90 minutes (p < 0.001). ♭Indicates 
significantly lower VO2 compared to 30, 60, and 90 minutes (p = 0.001). § Indicates a 
significantly lower VO2 compared to 90 minutes (p < 0.05). & Indicates a significantly lower 
HR compared to HE. ¢ Indicates significantly lower HR compared to 10, 30, 60, and 90 
minutes (p < 0.001). $ Indicates significantly lower HR compared to 30 minutes (p < 0.001). 
¶ Indicates significantly lower HR compared to 60 minutes (p < 0.001). £ Indicates 
significantly lower HR compared to 90 minutes (p < 0.001). ♪ Indicates a significantly lower 
RPE compared LE (p < 0.05). ¥ Indicates a significantly lower RPE compared to HE (p < 
0.05). ^ Indicates a significantly lower RPE compared to 30, 60, and 90 minutes (p < 0.001). 
# Indicates a significantly lower RPE compared to 60 and 90 minutes (p < 0.005).  
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Table 5: Mean (±SD) resting, 24-hour, and 72-hour CK activity and percent change (relative 
to rest) in CK during the prolonged running bouts for the LE and HE hormonal conditions.   
 
$ Indicates significantly lower CK compared to LE (p < 0.05). * Indicates significantly lower 
CK compared to 24 and 72 hours post running bout [main effect; F (1.279, 11.513) = 17.931, 
p ≤ 0.005]. Significant lower CK in HE [main effect; F (1, 9) = 5.442, p = 0.045]. £ Indicates 
significantly lower percent change in CK compared to LE (main effect; p < 0.05).  
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Table 6: Mean (±SD) IL-6 response and percent change (relative to rest) during the 
prolonged running bout for LE and HE hormonal conditions.  
 
*Indicates significantly higher IL-6 compared to resting values (main effect; p < 0.05). £ 
Indicates significantly lower IL-6 compared to IP values (main effect; p < 0.05). Significant 
lower IL-6 in HE (main effect; p = 0.011). ¥ Indicates significantly smaller percent change 
compared to IP (main effect; p < 0.001).  
 
 
 
CHAPTER V 
Discussion 
 The purpose of the present investigation was to determine if fluctuations in E2, as 
manipulated by menstrual cycle phase, influence IL-6 and IL-1β response to prolonged 
aerobic exercise. It was hypothesized that the magnitude of change from rest for both IL-6 
and IL-1β would be significantly greater at all measurement time points (rest, immediately 
post, 24-hour, and 72-hour post exercise) measured during LE compared to HE. These 
hypotheses were evaluated via examination of the response of 10 highly trained female 
runners who completed a 90-minute treadmill running bout at 67% of their VO2peak during 
both hormonal conditions, and returned 24 and 72-hours later for follow up blood collection.  
Hormonal Condition Determination 
 In the present study a marked difference in E2 was observed between hormonal 
conditions. Estrogen concentration was approximately two times higher for the HE compared 
to the LE (106.16 ± 20.55 vs. 53.35 ± 13.33 pg/ml, respectively). These results fell within the 
expected norms for the desired hormonal condition according to the ELISA kit used for 
analysis; midfollicular phase (LE) have levels ranging from 30 – 100 pg/ml, while midluteal 
(HE) have levels varying from 60 – 400 pg/ml (Human E2, Abnova, Walnut, CA). 
Furthermore, the difference in E2 concentration between hormonal conditions (~ 2 fold 
change) obtained in this study is similar to the E2 differences reported in previous research.  
Specifically, a majority of studies have reported a 1.3 – 4 fold increase in E2 between LE and 
HE conditions (Chiu et al., 2000; Hackney et al., 1991; Jilma et al., 1997; Konecna et al., 
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2000; Northoff et al., 2008; Timmons et al., 2005). However, Bouman et al. (2001) observed 
a 47-fold increase from LE to HE in women. It is unclear why the Bouman study order of 
magnitude is so different from others.   
Prolonged Treadmill Running Bout  
 The running speed of the subjects across both 90-minute running bouts corresponded 
to an average VO2 of 67.0 ± 1.6% VO2peak, slightly lower than the target intensity of 70% 
VO2peak. This difference between estimated and actual VO2 (L/min) was not significantly 
different, suggesting the appropriate treatment effect for intensity was obtained. Mean 
absolute VO2 responses between hormonal conditions were alike too; however, despite the 
running speed remaining relatively constant, VO2 gradually increased over each 90-minute 
period of exercise. The slight elevation in VO2 over time suggests the effort to maintain 
exercise intensity increased slightly, this was an expected outcome as a result of the cardiac 
drift phenomenon [see below] (Hausswirth & Lehenaff, 2001).  
 Exercise heart rate response between hormonal conditions was similar and displayed 
a gradual increase over the course of the 90-minutes.  At each subsequent time point, HR was 
significantly higher than the previous. This increase in HR is not unusual with prolonged 
exercise. Despite exercising in a thermoneutral environment, exercise for a prolonged 
duration increases body temperature (Hausswirth & Lehenaff, 2001). To abate the thermal 
load, cutaneous vasodilatation redirects blood to the skin and water within blood plasma is 
released from sweat glands for evaporative cooling (Hausswirth & Lehenaff, 2001; Plowman 
& Smith, 2003). These two actions reduce plasma volume and venous return; in order to 
maintain blood flow to active tissues subsequently maintaining exercise intensity, HR must 
increase - the cardiac drift phenomenon (Hausswirth & Lehenaff, 2001; Plowman & Smith, 
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2003). This concept is further supported in the current study by the reduced plasma volume 
observed following both prolonged running bouts.  
 Despite identical exercise workloads between the two bouts, RPE measures were 
significantly different between hormonal conditions. Ratings of perceived exertion were 
significantly higher in LE compared to HE at 10 minutes; however, at 30 and 60 minutes, 
RPE was significantly higher for the HE. While the difference in RPE early in the run is 
statistically significant, the differences in RPE later in the exercise are more clinically 
relevant. This difference in perception of effort is not atypical; previous research has reported 
similar findings between different hormonal conditions (Hackney et al., 1991).  The 
mechanism behind the discrepancy is unclear; however, the divergence could be the result of 
physiological differences between menstrual cycle phases. Research has shown during the 
HE periods, women generally retain water, resulting in weight gain (Constantini et al., 2005). 
This idea is supported in the present study by the slightly higher weight and lower specific 
gravity for the HE condition. Moreover, it is believed during HE, concurrent to the water 
retention, women have elevated basal core temperature (Constantini et al., 2005). Increased 
basal core temperature reduces the capacity to effectively thermoregulate translating to 
increased perception of effort (Constantini et al., 2005). Regrettably, core temperature was 
not measured in the present study. 
Furthermore, in both hormonal conditions, RPE gradually increased over the course 
time. The increase in perceived effort can be explained by the prolonged nature of the 
exercise. The ability to exercise for a prolonged period of time is highly dependent on 
motivation, environment, and hydration and nutrition status (Plowman & Smith, 2003). In 
this particular instance, subjects did not consume carbohydrates (CHO) during the run but 
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drank water ad libitum. The lack of CHO supplementation could have led to glycogen 
depletion potentially causing fatigue and a gradual increase in effort perception.  
In general the VO2, HR, and RPE response observed during the 90-minute run 
followed the expected physiological outcome and were extremely similar between hormonal 
conditions. This suggests any differences in blood measure responses to exercise, such as CK 
and IL-6, were the result of differences in hormonal condition.  
Blood Responses to Prolonged Treadmill Running Bout 
Creatine Kinase 
A significant interaction effect of hormonal condition by time was observed for CK 
activity. Further analyses showed that CK levels were trending toward significantly higher 
24-hours post and were significantly higher 72-hours post exercise for the LE condition 
comparatively. These results are in line with previous research and support the notion that 
more muscle damage is accrued following exercise in LE periods compared to HE periods 
(Carter et al., 2001; Tiidus et al., 2001). Also, the levels of CK found following exercise in 
each condition are in line with what has previously been reported following exercise (Carter 
et al., 2001; Tiidus et al., 2001). Carter et al., (2001) observed slightly higher CK levels 24-
hours following exercise in both LE and HE conditions and saw a continued increased in CK 
for the LE condition at 72-hours, comparatively. This disparity at 24 and 72-hours could be 
related to the mode of exercise; the subjects in the study of Carter et al. ran at a -10% grade, 
while in the current investigation subjects ran on a flat surface. The downhill running elicits a 
greater eccentric component to the activity, known to induce more rapid and greater muscle 
damage (Bar et al., 1988). Conversely, while Tiidus et al. (2001) observed a significantly 
reduced CK response in E2 supplemented rats versus non-supplemented, the overall CK 
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response following the 60-minute run was slightly lower in both hormonal conditions 
compared to the present study. Creatine kinase levels were only measured once, one hour 
following exercise. In general, CK levels increase slowly, peaking somewhere between 24 
and 96 hours following exercise depending on the mode, duration, and intensity of the 
exercise bout (Carter et al., 2001; Bruunsgaard et al., 1997; Kendall & Eston, 2002). Given 
only one time point measurement shortly after exercise in the Tiddus et al. study, the 
maximum amount of CK in the blood may not have been present, resulting in lower overall 
CK values. The present investigation measured CK at 24 and 72-hours following exercise, 
with levels peaking at 24-hours in both hormonal conditions.   
The mechanism behind the difference in CK response phenomenon to varying 
hormonal conditions is not entirely understood, but believed to be the result of E2’s lipophilic 
nature and anti-oxidant capabilities (Enns & Tiidus et al., 2010; Kendall & Easton, 2002). 
Estrogen is able to easily implant itself within the cellular bilayer via its lipid backbone while 
the anti-oxidant nature reduces production of reactive oxygen species from membrane lipids 
and proteins resulting in a more rigid membrane (Enns & Tiidus et al., 2010; Kendall & 
Easton, 2002). The more stable and rigid membrane attenuates damage thereby potentially 
reducing CK release from muscle (Bar et al., 1988; Carter et al., 2001).  
Interleukin-6 
While no interaction effect of hormonal condition and time was observed for absolute 
concentration, IL-6 did significantly increase following exercise during both hormonal 
conditions and was significantly elevated in the LE session comparatively. Resting IL-6 at 
LE was slightly higher in the present investigation compared to others (Brenner et al., 1999; 
Bruusnsgaard et al., 1997; Chiu et al., 2000; Jilma et al., 1997; Konecna et al., 2000). These 
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studies reported resting IL-6 values ranging from 0.5 - 1.5 pg/ml, approximately 4 times 
lower than the present investigation. It is unclear why LE rest values were slightly higher 
presently compared to other studies. This could be a function of; a) assay technique 
differences between studies, b) small sample size adding to variability, c) timing of the 
resting blood draw. Future studies are necessary to elucidate why this occurred. 
Immediate post exercise IL-6 was 4.9 times higher compared to rest (i.e. main effect); 
similar to the findings reported by Bruunsgaard et al. (1997) and Brenner et al. (1999). 
However, others have reported significantly greater increases in IL-6 following exercise. 
Ostrowski et al. (1999) saw a 75-fold increase in IL-6 following a marathon (3 hrs and 27 
min). Nieman et al. (1998) observed a 51-fold increase in IL-6 following a 2.5 hour run at 
75% VO2max. The disparity in results could be related to differences in the intensity and 
duration of the exercise bout used in the studies.  
Subjects were either self-directed or entirely restricted from ingesting CHO during 
these experiments. Without adequate CHO consumption, muscle glycogen depletion can 
occur 1 to 3 hours into exercise depending on intensity (Coyle, 1995). This reduction in 
glycogen is believed to trigger IL-6 release from muscle (Febbraio & Pederson, 2002). 
Interleukin-6 stimulates glucose production and secretion by direct activation of 
gluconeogenic pathways at the liver and indirectly by lipolysis at adipose tissue and 
increased release of cortisol via HPA axis (Febbraio & Pederson, 2002). This increase in 
glucose production and secretion will help to maintain plasma glucose levels (compensating 
for the low glycogen) subsequently maintaining exercise intensity (Coyle, 1995). The 
subjects in the Ostrowski et al. and Nieman et al. studies, due to the intensity-duration of 
their efforts, were probably in a hypoglycemic state, increasing greatly IL-6 secretion. While 
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subjects did not ingest CHO during the run in the present study, exercise did cease at 90-
minutes, thereby potentially reducing the magnitude of the IL-6 response and muscle 
glycogen depletion occurance.  
By 24-hours, IL-6 had returned to near baseline values (i.e. main effect). Few studies 
have assessed IL-6 concentration further than 24-hours post exercise; however, those studies 
that have, reported parallel findings with the present investigation (Brenner et al., 1999; 
Bruunsgaard et al., 1999).    
Interleukin-6 concentration at 72-hours post exercise was similar to those observed at 
rest. Additionally, IL-6 was significantly lower at 72-hours post exercise compared to IP. 
This finding is not unusual considering IP presented peak IL-6 concentrations, creating the 
largest difference between two time points.  
It is important to note the references cited above used primarily male cohorts in their 
design (Bruunsgaard et al., 1997; Brenner et al., 1999; Nieman et al., 1998; Ostrowski et al., 
1999). Given the known hormonal divergence between men and women, the differences in 
the magnitude of IL-6 responses observed may be related somewhat to gender. Women 
generally have less muscle mass, reducing the amount of tissue susceptible to muscle damage 
and oxidative stress (Janssen et al., 2000; Plowman & Smith, 2003). Less oxidative stress 
reduces production of reactive oxygen species resulting in a smaller pro-inflammatory 
cytokine response (Kendall & Eston, 2002). Additionally, E2 is known to modulate metabolic 
pathways; for example, women are better able to utilize fat for energy compared to men 
(Constantini et al., 2005). With increased fat utilization, plasma glucose levels are spared, 
further reducing likelihood of glycogen depletion during exercise subsequently decreasing 
IL-6 response (Constantini et al., 2005; Plowman & Smith, 2003).   
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Despite a main effect of hormonal condition for IL-6 concentration, no main effect of 
hormonal condition was observed for relative IL-6 values (change scores). It was 
hypothesized that the magnitude of change IP, 24-hours, and 72-hours post-exercise would 
be of a greater extent for the LE session, respectfully. This was not the case in the present 
study; the percent change from rest in IL-6 was not of a greater magnitude for the LE 
compared to HE condition. This finding is in agreement with those previously reported 
(Timmons et al., 2005), suggesting E2 does not play as great a role in cytokine response 
following exercise as previously thought.  
The lack of interaction effects for absolute and relative IL-6 values may be the result 
of limitations in the current study design. It is possible the duration and intensity of the 
exercise session was not great enough to elicit significant differences in IL-6 between phases. 
Exercise lasting more than 2.5 hours at high intensities had upwards of 50-fold increases in 
IL-6 (Nieman et al., 2001; Ostrowski et al., 1999). If not enough damage or stress was 
accrued during the session it may mask the influence of E2. Additionally, the sample size was 
too small. Original power calculations required 10 subjects to complete two exercise sessions 
at different hormonal conditions; however, only five completed both exercise sessions, while 
five completed one prolonged exercise session thereby limiting the statistical strength of the 
design.  
The greater IL-6 concentration observed for the LE condition compared to HE (i.e. 
main effect) in the present investigation may be explained by E2’s protective effect on muscle 
(Enns & Tiidus et al., 2010; Kendall & Easton, 2002). A single bout of exercise has been 
shown to cause acute muscle damage, as determined from changes in CK levels in the blood 
(Bruunsgaard et al., 1997; Bar et al., 1988; Carter et al., 2001). Muscle damage is a form of 
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trauma; this tissue trauma is known to stimulate the immune system, specifically the innate 
branch (Bruunsgaard et al., 1998; Moldoveanu et al., 2001; Pederson et al., 1998). The innate 
response consists of direct release of pro-inflammatory cytokines (e.g. IL-6) and migration of 
neutrophils to the site of damage via chemoattractants (Abbas et al., 2000; Pederson et al., 
1998). Neutrophils will further draw monocytes to the area (Nathan, 2006; Pederson et al., 
1998). Monocytes will stimulate additional production and secretion of IL-6 (Corwin, 2000; 
Moldoveanu et al., 2001). This augmentation in pro-inflammatory cytokines further up-
regulates the adaptive branch of the immune system (Abbas et al., 2000; Corwin, 2000; 
Smith, 2004). Consequently, not all lines of the adaptive immune system are activated the 
same; during tissue trauma only the humoral branch is activated, while the cell-mediated 
branch in suppressed (Diehl & Rincon, 2000; Faist et al., 1996; Smith, 2004). The cell-
mediated branch is necessary for protection against bacterial and viral infections [see Figure 
3 below] (Abbas et al., 2000; Smith, 2004). Contraction of a virus may alter not only the 
nature of a training session but the ability to train at all, consequently affecting performance. 
Hence, periods of high E2 may provide protection against muscle damage, thereby 
attenuating CK release and reducing susceptibility to overt inflammatory reactions. This idea 
is purely speculative given the lack of a significant interaction effect for hormonal condition 
and time within the present study.  
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Figure 3: Typical immune response to trauma, stress, infection, and inflammation (adapted 
from Hackney, [2011]). 
 
Interleukin-1β 
 In the present investigation levels of IL-1β were unobtainable due to technical 
problems. In particular, the standard curve for the assay was invalid. Without a standard 
curve, no reference point exists to convert unknown sample values to concentrations. This 
technical error was not observed with the IL-6 assay.  
It was hypothesized that the change in IL-1β would be of a significantly greater 
magnitude at all time point measurements in the LE compared to the HE based upon previous 
research (Lynch et al., 2001; Morshita et al., 1999; Nieman et al, 2001; Ostrowski et al., 
1997). Northoff et al., (2008) indirectly assessed IL-1β by measuring gene expression of IL-
1ra in eumenhorreic women following 60 minutes of running at 93% of individual anaerobic 
threshold (~ 60 – 70% VO2max). Interleukin-1 receptor alpha (IL-1ra) is the anti-
inflammatory protein that inhibits IL-1β action. In Northoff et al.’s study, IL-1ra expression 
was significantly downregulated following exercise in the HE condition, while expression 
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was trending towards a significant upregulation in the LE condition. These results suggest a 
pro-inflammatory state during periods of high E2. This is the only known study to assess E2 
influence on IL-1β following exercise.  
Literature on the influence of E2 on IL-1β at rest is conflicting. Some report higher 
IL-1β concentration in HE compared to LE (Cannon & Dinarello, 1985; Bouman et al., 2001; 
Willis et al., 2003). While others suggest just the opposite, lower IL-1β concentration in HE 
comparatively (Lynch et al., 1994; Morshita et al., 1999). With such limited research 
available on the influence of E2 on IL-1β at rest and in response to exercise, additional 
studies must be conducted to clarify the relationship. The IL-1β results of the present study 
would have significantly added to the limited literature. It is regrettable the data could not be 
obtained.  
Conclusion: 
 In conclusion, IL-6 does in fact increase in both LE and HE conditions immediately 
following exercise compared to rest, returning to near baseline levels by 24-hours. However, 
the influence of hormonal condition on cytokine response to exercise is not quite as clear. 
Interleukin-6 concentration was significantly higher (main effect) in the LE session 
compared to the HE session; however, the magnitude of change from rest to IP, 24-hours, 
and 72-hours following exercise was not different between the hormonal conditions. Due to 
the lack of statistical significance for changes in IL-6 (interaction), it cannot be completely 
suggested that highly trained female runners should alter their training program – decreasing 
training volume during periods of low E2. Although the CK findings do suggest that a 
slightly greater degree of muscle damage will occur following exercise in a LE condition. 
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Given the limited research present on the influence of E2 on cytokine response to exercise, 
additional research is imperative.  
Limitations 
There are several limitations to the current study. One it appears that the sample size 
was too small. Interleukin-6 data was underpowered, as the β = 0.66, rather the more 
acceptable 0.80. In order to reach statistical significance additional subjects are required. 
Furthermore, post-menopausal, amenorrheic, and oligomenorrheic women have different E2 
hormonal profiles compared to eumenorrheic and oral contraceptive users, potentially 
altering their immune response following exercise. Therefore, the results of this study are 
only relevant to eumenorrheic and oral contraceptive users. Lastly, immune response is 
modulated by the mode of exercise – eccentric exercise imposes a greater response compared 
to concentric (Bruunsgaard et al., 1997; Nieman et al., 1998). Running has an eccentric 
component; hence, theses results may be only applicable to runners.  
Future Directions 
Future studies should repeat the experiment with a greater number of subjects to 
reach a statistical power of 0.80. Additionally, only one cytokine was analyzed in the current 
study. In order to have a more comprehensive understanding of the relationship between E2 
and immune response, additional cytokines, both pro- and anti-inflammatory, should be 
studied following exercise at different E2 levels. Lastly, other sex hormones are known to 
fluctuate across the menstrual, specifically progesterone (Williams & Larsen, 2003). Some 
have suggested a relationship exists between progesterone and cytokines at rest (Angstwurm 
et al., 1997; Morshita et al., 1999). Future studies should further explore this potential 
relationship with respect to exercise.  
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APPENDIX A 
Phone Screening Script 
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Phone Script 
1. Hello “name.” My name is Ashley Kallman from the Applied Physiology Laboratory 
at University of North Carolina at Chapel Hill. I am conducting a research study 
looking at the influence of different phases of the menstrual cycle on immune 
response to prolonged treadmill running. Would you be interested in participating? 
a. If yes, then ask: “I need to ask you a few questions regarding your health and 
training status. Do you mind if I ask you these questions?” 
i. If no, proceed to question 2 
ii. If yes, thank the individual for their time and explain: “Certain criteria 
must be met in order to participate in the study. I am unable to 
determine if you meet the criteria; therefore, I am unable to enroll you 
in the study. Thank you for your time, have a nice day.” 
b. If no, then “thank you for your time have a nice day.”  
2. Are you between the ages of 18 and 30? 
a. If yes, proceed to 3 
b. If no, thank the individual and explain: “In order to participate in the study 
you must be between the ages of 18 and 30. Since you do not fall into the 
range I cannot enroll you in the study. Thank you for your time, have a nice 
day.” 
3. Are you currently using oral contraceptive? 
a. If yes, thank the individual and explain: “In order to participate in the study 
you cannot be using an oral contraceptive. Since you are using an oral 
contraceptive I cannot enroll you in the study. Thank you for your time, have 
a nice day.” 
b. If no, proceed to question 4 
4. Do you have a regular menstrual cycle? Meaning, does your cycle last approximately 
25-35 days? 
a. If yes, proceed to 5 
b. If no, thank the individual and explain: “In order to participate in the study 
you must have a normal menstrual cycle duration between 25-35 days. Since 
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you do not have a normal menstrual cycle duration I cannot enroll you in the 
study. Thank you for your time, have a nice day.” 
5. How long does your cycle typically last? Meaning, how many days from the start of 
menses to the next start of menses? 
6. How long has your cycle been regular? 
a. If more than 6 months, proceed to question 7 
b. If less than 6 months, thank the individual and explain: “In order to participate 
in the study you must have a regular cycle for at least 6 months. Since your 
cycle has not been regular for at least 6 months I cannot enroll you in the 
study. Thank you for your time, have a nice day.” 
7. Are you knowingly pregnant or trying to become pregnant? 
a. If yes, thank the individual for their time and explain: “In order to participate 
in the study you cannot be pregnant or trying to become pregnant. Since you 
are or trying to become pregnant I cannot enroll you in the study. Thank you 
for your time, have a nice day.” 
b. If no, proceed to question 8 
8. Have you participated in a half-marathon race or a race of an equivalent distance 
within the last year? 
a. If yes, proceed to question 8 
b. If no, thank the individual and explain: “In order to participate in the study 
you must have completed a half marathon race or a race of equivalent distance 
in order to participate within the last year. Since you have not completed such 
a race I cannot enroll you in the study. Thank you for your time, have a nice 
day.” 
9. Approximately when did the race take place? 
10. What was your official finishing time? 
a. If time is less than 2 hours 30 minutes proceed to question 11 
b. If time is greater than 2 hours 30 minutes thank the individual and explain: “In 
order to participate in the study you must have completed a half marathon or a 
race of equivalent distance within 2 hours 30 minutes. Since you did not 
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complete within the time frame I cannot enroll you in the study. Thank you 
for your time, have a nice day.” 
11. Have you sustained any recent injury for example, patellar tendonitis, illiotibial band 
syndrome, etc. within the last year? 
a. If yes, thank the individual and explain: “In order to participate in the study 
you must have no history of injury within the last year. Since you have 
sustained an injury I am unable to enroll you in the study. Thank you for your 
time, have a nice day.” 
b. If no, proceed to question 12 
12. Are you currently engaged in consistent aerobic training? 
a. If yes, proceed to question 13 
b. If no, thank the individual and explain: “In order to participate in the study 
you must be currently involved in aerobic training. Since you are not I cannot 
enroll you in the study. Thank you for your time, have a nice day.” 
13. How many days a week are you currently training? 
a. If more than 3 days proceed to question 14 
b. If less than 3 days thank the individual and explain: “In order to participate 
you must aerobically training a minimum of 3 days per week. Since you are 
not I cannot enroll in you the study. Thank you for your time, have a nice 
day.” 
14. What is the average duration of your training sessions? 
a. If the sessions are at least 45 minutes they are included.  
b. If less than 45 minutes per session thank the individual and explain: “In order 
to participate in the study your training sessions must be at least 45 minutes in 
duration. Since they are not I cannot enroll you in the study. Thank you for 
your time, have a nice day.” 
If the subject meets all the inclusion criteria then the orientation/familiarization session will 
be scheduled.  
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APPENDIX D 
Physical Screening Form 
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APPENDIX E 
Data Collection Forms 
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Prolonged Session 1 
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Prolonged Session 2 
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APPENDIX F 
Assay Information 
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Estrogen Assay (Copyrighted by Abnova, Walnut, CA) 
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